EOS Med Chem Impurity Stock 20201029-2

EOS Med Chem is serving more than 100 Pharma companies, we have the original Drug Discovery Compounds, Like Impurity, small molecule and inhibitor.

Impurity we keep stock more than 80000, most in stock, we are World Sole Original Supplier, Each impurity we could supply: Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA.

EOS Med Chem Quotation include: Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, COA, MSDS.

Welcome to visit: our youtube:  https://youtu.be/r5cJdXKNXHk 

Contact:

EOS Med Chem, Medicinal Chemical is Big

執大象，天下往，往而無害，安平泰

Ms Nina

Youtube: https://youtu.be/r5cJdXKNXHk 

E: info@eosmedchem.com 

W: www.eosmedchem.com 

Tel: 0086-531-69905422

SALE OFFICE: 16F, China Overseas Plaza, Jinan City, China

 trans-4-Methyl-L-proline Hydrochloride, CAS: 365280-18-8, stock: 8.5g, assay: 97.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₆H₁₂ClNO₂.

2-​(5-​Acetyl-​2-​ethoxyphenyl)​-​5-​methyl-​7-​propyl-imidazo[5,​1-​f]​[1,​2,​4]​triazin-​4(1H)​-​one, CAS: 358390-43-9, stock: 6.9g, assay: 96.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₉H₂₂N₄O₃.

2-Ethoxybenzamidine Hydrochloride, CAS: 18637-00-8, stock: 9.3g, assay: 98.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₉H₁₃ClN₂O.

N-Demethyl Vandetanib-d8, CAS: /, stock: 4.5g, assay: 98%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₁H₁₄D₈BrFN₄O₂.

O-Demethyl Vandetanib, CAS: 910298-60-1, stock: 6.7g, assay: 96.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₁H₂₂BrFN₄O₂.

trans-Doxercalciferol, CAS: 74007-20-8, stock: 5.8g, assay: 98.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₈H₄₄O₂.

trans-Doxercalciferol-d3, CAS: /, stock: 2.9g, assay: 98.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₈H₄₁D₃O₂.

2-Ethoxybenzenecarboximidic Acid Hydrazide Hydrochloride, CAS: /, stock: 6.1g, assay: 97.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₉H₁₃N₃O  •HCi.

2-Ethoxybenzimidohydrazide, CAS: 889943-46-8, stock: 9.3g, assay: 98%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₉H₁₃N₃O.

O-Demethyl Vandetanib-d4, CAS: 1346599-97-0, stock: 1.2g, assay: 98.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₁H₁₈D₄BrFN₄O₂.

Vandetanib, CAS: 443913-73-3, stock: 2.3g, assay: 96.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₂H₂₄BrFN₄O₂.

2,4-Dicyano-3-(3,4-dihydroxyphenyl)-N1,N1,N5,N5-tetraethylpentanediamide, CAS: /, stock: 6.4g, assay: 98.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₁H₂₈N₄O₄.

3-(1,4-Dihydro-5-methyl-4-oxo-7-propylimidazo[5,1-f][1,2,4]triazin-2-yl)-4-ethoxybenzenesulfonic Acid, CAS: 437717-43-6, stock: 9.2g, assay: 97.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₇H₂₀N₄O₅S.

3-(N-(2-Ethoxy-2-oxoacetyl)butyramido)-2-hydroxybut-2-enoic Acid Ethyl Ester, CAS: /, stock: 1.7g, assay: 98.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₄H₂₁NO₇.

Vandetanib N-Oxide, CAS: 1797030-22-8, stock: 5.3g, assay: 97.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₂H₂₄BrFN₄O₃.

Vandetanib-d4, CAS: 1215100-18-7, stock: 7g, assay: 98.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₂H₂₀D₄BrFN₄O₂.

2,4-Dicyano-N1,N1,N5,N5-tetraethyl-3-(4-hydroxy-3-methoxy-5-nitrophenyl)pentanediamide, CAS: /, stock: 8.7g, assay: 96.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₂H₂₉N₅O₆.

2,​5-​Dimethylaniline(2,5-Xylidine), CAS: 95-78-3, stock: 9.5g, assay: 97.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₈H₁₁N.

4-Ethoxy-3-(5-methyl-4-oxo-7-propyl-3,4-dihydro-imidazo[5,1-f][1,2,4]-triazin-2-yl)benzene-sulfonyl Chloride, CAS: 224789-26-8, stock: 9.3g, assay: 96.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₇H₁₉ClN₄O₄S.

Universal FA/VB9(Folic Acid/Vitamin B9) ELISA Kit (96T), CAS: /, stock: 5.5g, assay: 98%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  /.

7-Despropyl 7-Methyl Vardenafil, CAS: /, stock: 3.7g, assay: 96.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₁H₂₈N₆O₄S.

7-Despropyl 7-Methyl Vardenafil-d5, CAS: /, stock: 4.4g, assay: 96.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₁H₂₃D₅N₆O₄S.

Universal VB12(Vitamin B12) ELISA Kit (96T), CAS: /, stock: 5.1g, assay: 98.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  /.

7-Despropyl 7-Phenyl Vardenafil, CAS: 1255919-01-7, stock: 2.8g, assay: 96.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₆H₃₀N₆O₄S.

Desethyl Vardenafil Dihydrochloride, CAS: /, stock: 9.3g, assay: 97.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₁H₃₀Cl₂N₆O₄S.

Ethyl 2-((2-(4-Ethoxy-3-(5-methyl-4-oxo-7-propyl-1,4-dihydroimidazo[5,1-f][1,2,4]triazin-2-yl)phenylsulfonamido)ethyl)amino)-2-oxoacetate, CAS: /, stock: 1.5g, assay: 96.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₃H₃₀N₆O₇S.

N-(1-(3-(2-Ethoxyphenyl)-6-oxo-1,6-dihydro-1,2,4-triazin-5-yl)ethyl)acetamide, CAS: /, stock: 9.6g, assay: 97.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₅H₁₈N₄O₃.

N-(2-Aminoethyl)-3-(1,4-dihydro-5-methyl-4-oxo-7-propylimidazo[5,1-f][1,2,4]triazin-2-yl)-4-ethoxybenzenesulfonamide, CAS: 448184-52-9, stock: 4g, assay: 98.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₉H₂₆N₆O₄S.

N-[1-[3-(2-Ethoxyphenyl)-2,5-dihydro-5-oxo-1,2,4-triazin-6-yl]ethyl]acetamide, CAS: 1417529-59-9, stock: 2g, assay: 97.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₅H₁₈N₄O₃.

Pseudo Vardenafil, CAS: 224788-34-5, stock: 6.4g, assay: 96.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₂H₂₉N₅O₄S.

5-Carboxyvanillin, CAS: 02/08/3507, stock: 6.9g, assay: 97.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₉H₈O₅.

Vitamin B12-O5’-NHS Ester, CAS: /, stock: 10g, assay: 97.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₇₁H₉₅CoN₁₅O₁₉P.

S-Desethylpiperidino S-[2-Carboxyl-2-oxo-ethyl-(2-aminoethyl)amino] Vardenafil, CAS: 448184-56-3, stock: 1.9g, assay: 97.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₁H₂₆N₆O₇S.

S-Desethylpiperidino Vardenafil Acid Sodium Salt, CAS: /, stock: 6.1g, assay: 96.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₇H₁₉N₄NaO₅S.

Vardenafil 4-Desethoxy 6-Ethoxide, CAS: /, stock: 2.6g, assay: 98.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₃H₃₂N₆O₄S.

Vitamin D2 Impurity, CAS: /, stock: 9.8g, assay: 98.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₇H₃₇O.

Vardenafil Acetyl Analogue, CAS: 1261351-28-3, stock: 3.6g, assay: 96.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₅H₃₄N₆O₃.

Vardenafil Acetyl-d5 Analogue, CAS: 1330171-51-1, stock: 7.2g, assay: 97.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₅H₂₉D₅N₆O₃.

Vitamin D2 Propiononitrile, CAS: /, stock: 3.2g, assay: 98.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₃₁H₄₇NO.

Vardenafil Dimer, CAS: 1255919-03-9, stock: 3.7g, assay: 98.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₃₈H₄₆N₁₀O₈S₂.

Vitamin D2 SO2 Adduct, CAS: 87680-65-7, stock: 6.7g, assay: 98.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₈H₄₄O₃S.

Vitamin D2 Sulfate Sodium Salt, CAS: 85704-61-6, stock: 3.8g, assay: 96%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₈H₄₃NaO₄S.

Vardenafil hydrochloride trihydrate, CAS: 330808-88-3, stock: 4.9g, assay: 97.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₃H₃₂N₆O₄S • HCl • 3(H  ₂O).

Vitamin D2-d6 β-D-Glucuronide Sodium Salt, CAS: /, stock: 5.7g, assay: 97.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₃₄H₄₅D₆NaO₇.

Vitamin D2-d6 Sulfate Sodium Salt, CAS: /, stock: 2.3g, assay: 98.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₈H₃₇D₆NaO₄S.

Vitamin D3 Decanoate (>90%), CAS: 158180-04-2, stock: 7g, assay: 98.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₃₇H₆₂O₂.

Vitamin D3 α-D-Glucuronide Methyl Ester Triacetate, CAS: /, stock: 3.9g, assay: 97.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₄₀H₆₀O₁₀.

Vitamin D3 β-D-Glucuronide Methyl Ester Triacetate, CAS: /, stock: 5.6g, assay: 96.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₄₀H₆₀O₁₀.

Vanillin 2’,3’,4’,6’-O-Tetraacetyl-β-D-Glucoside, CAS: 23598-07-4, stock: 6.4g, assay: 98.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₂H₂₆O₁₂.

Vanillin Azine, CAS: 1696-60-2, stock: 1.2g, assay: 97.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₆H₁₆N₂O₄.

Vitamin D3 Octanoate (90%), CAS: 927822-16-0, stock: 5.6g, assay: 96.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₃₅H₅₈O₂.

Vitamin D4, CAS: 511-28-4, stock: 1.2g, assay: 98.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₈H₄₆O.

Vitamin D4-d3, CAS: /, stock: 3.6g, assay: 97%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₈H₄₃D₃O.

Vitamin D4-d5, CAS: /, stock: 3.9g, assay: 97.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₈H₄₁D₅O.

Vitamin D5, CAS: 71761-06-3, stock: 3.8g, assay: 96.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₉H₄₈O.

Vitamin E Acetate, CAS: 7695-91-2, stock: 3.4g, assay: 98.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₃₁H₅₂O₃.

Vitamin K1 2,3-Epoxide, CAS: 25486-55-9, stock: 9.5g, assay: 98.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₃₁H₄₆O₃.

Windaus Ketone, CAS: 55812-80-1, stock: 5.8g, assay: 98.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₉H₃₂O.

ZK 159222, CAS: 156965-15-0, stock: 9.7g, assay: 97.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₃₂H₄₈O₅.

ZK 159222-d4, CAS: /, stock: 4.9g, assay: 98.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₃₂H₄₄D₄O₅.

ZK 168281, CAS: 186371-96-0, stock: 6.5g, assay: 96.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₃₂H₄₆O₅.

ZK 168281-d4, CAS: /, stock: 7.2g, assay: 98.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₃₂H₄₂D₄O₅.

[(2Z)-2-[(3S,5R)-3,5-Bis[[(1,1-dimethylethyl)dimethylsilyl]oxy]-2-methylenecyclohexylidene]ethyl]diphenylphosphine Oxide, CAS: 81522-68-1, stock: 7.3g, assay: 98.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₃₃H₅₁O₃PSi₂.

[S-(Z)]-[2-[5-[[(1,1-Dimethylethyl)dimethylsilyl]oxy]-2-methylenecyclohexylidene]ethyl]diphenylphosphine Oxide, CAS: 100858-27-3, stock: 1.4g, assay: 97.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₇H₃₇O₂PSi.

[[[(2E,6E,10E,14E,18E,22E)-3,7,11,15,19,23,27-Heptamethyl-13-(phenylthio)-2,6,10,14,18,22,26-octacosaheptaen-1-yl]oxy]methyl]-benzene, CAS: 1218785-58-0, stock: 4.7g, assay: 96.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₄₈H₆₈OS.

2-[N-(9-Fluorenylmethoxycarbonyl)-N-decylamino]ethanal, CAS: 239088-22-3, stock: 9.7g, assay: 99%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₇H₃₅NO₃.

5-Bromo-6-chloro-3-indoxyl Phosphate, Disodium Salt Monohydrate, CAS: 404366-59-2, stock: 4.5g, assay: 96.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₈H₄BrClNNa₂O₄P.

Decyl(2-hydroxyethyl)-carbamic Acid 9H-Fluoren-9-ylmethyl Ester, CAS: 239088-19-8, stock: 3.6g, assay: 96.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₇H₃₇NO₃.

Desvancosaminyl Vancomycin Trifluoroacetic Acid Salt Hydrate (>90%), CAS: 101485-50-1, stock: 2.1g, assay: 99%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₆₁H₆₃Cl₂F₃N₈O₂₄ xH₂O.

Didechloro Vancomycin•xHCl, Technical Grade(Vancomycin Impurity), CAS: /, stock: 9.9g, assay: 98.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₆₆H₇₇N₉O₂₄ xHCl.

N-Methylvancomycin, CAS: 99759-13-4, stock: 9g, assay: 96.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₆₇H₇₇Cl₂N₉O₂₄.

Norvancomycin Trifluoroacetic Acid Salt >85%, CAS: /, stock: 7.6g, assay: 96.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₆₅H₇₃Cl₂N₉O₂₄ (free amine).

Vancomycin, CAS: 1404-90-6, stock: 8.1g, assay: 96.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₆₆H₇₅Cl₂N₉O₂₄.

Vancomycin Aglycon, CAS: 82198-76-3, stock: 6.6g, assay: 97.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₅₃H₅₂Cl₂N₈O₁₇.

Vancomycin Aglycon Trifluoroacetic Acid Salt Hydrate, CAS: /, stock: 3.5g, assay: 97.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₅₅H₅₃Cl₂F₃N₈O₁₉ xH₂O.

Vancomycin CDP-1, CAS: 55598-85-1, stock: 4.5g, assay: 97.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₆₆H₇₄Cl₂N₈O₂₅.

Vancomycin Hexapeptide, CAS: 115236-65-2, stock: 6.4g, assay: 96.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₅₉H₆₂Cl₂N₈O₂₃.

Vancomycin Hydrochloride, CAS: 1404-93-9, stock: 2.4g, assay: 96.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₆₅H₇₃Cl₂N₉O₂₅ • x(HCl).

Vancomycin Methyl Ester, CAS: 250273-66-6, stock: 3.8g, assay: 96.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₆₇H₇₇Cl₂N₉O₂₄.

Vancomycin Monohydrochloride, CAS: 197638-25-8, stock: 8.4g, assay: 98.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₆₆H₇₆Cl₃N₉O₂₄.

(+/-)-2-Propyl-4-pentenoic Acid Methyl Ester-d3, CAS: /, stock: 6.6g, assay: 96.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₉H₁₃D₃O₂.

(E,Z)-2-Propyl-2,4-pentadienoic Acid, CAS: 72010-18-5, stock: 8.3g, assay: 99%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₈H₁₂O₂.

(E,Z)-2-Propyl-2-pentenoic Acid, CAS: 60218-41-9, stock: 5g, assay: 97.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₈H₁₄O₂.

(E/Z)-2-Propyl-2,4-pentadienoic Acid Ethyl Ester-d5, CAS: /, stock: 3.8g, assay: 99%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₀H₁₁D₅O₂.

(E/Z)-2-Propyl-2,4-pentadienoic Acid Methyl Ester, CAS: 134257-62-8, stock: 5.3g, assay: 97.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₉H₁₄O₂.

(E/Z)-2-Propyl-2,4-pentadienoic Acid Methyl Ester-d3, CAS: /, stock: 3.4g, assay: 98.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₉H₁₁D₃O₂.

(E/Z)-2-Propyl-2-pentenoic Acid Ethyl Ester, CAS: 90124-74-6, stock: 3.7g, assay: 97.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₀H₁₈O₂.

(E/Z)-2-Propyl-2-pentenoic Acid Ethyl Ester-d5, CAS: /, stock: 7.9g, assay: 97.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₀H₁₃D₅O₂.

(E/Z)-2-Propyl-2-pentenoic Acid Methyl Ester, CAS: 797753-90-3, stock: 8g, assay: 97%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₉H₁₆O₂.

(E/Z)-2-Propyl-2-pentenoic Acid Methyl Ester-d3, CAS: /, stock: 2.6g, assay: 97.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₉H₁₃D₃O₂.

2,2,3,3-Tetramethylcyclopropanecarboxylic Acid, CAS: 15641-58-4, stock: 2.5g, assay: 98.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₈H₁₄O₂.

2,2-Dipropylvaleramide, CAS: 52061-73-1, stock: 9.6g, assay: 97.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₁H₂₃NO.

2,4,6-Triisopropylbenzenesulfonyl Chloride, CAS: 6553-96-4, stock: 2.8g, assay: 98.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₅H₂₃ClO₂S.

2-Methyl (E)-2-Methyl-2-pentenoate, CAS: 1567-14-2, stock: 6.8g, assay: 96.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₇H₁₂O₂.

2-Propyl-(E)-2-pentenoic Acid, CAS: 33786-47-9, stock: 4.6g, assay: 96.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₈H₁₄O₂.

2-Propyl-4-pentenoic Acid Methyl Ester, CAS: 210690-89-4, stock: 5.4g, assay: 98.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₉H₁₆O₂.

2-Propylglutaric Acid, CAS: 32806-62-5, stock: 2.6g, assay: 98.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₈H₁₄O₄.

2-Propylhexanoic Acid, CAS: 3274-28-0, stock: 1.9g, assay: 97.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₉H₁₈O₂.

2-Propylhexanoic Acid Ethyl Ester, CAS: 161011-36-5, stock: 3.5g, assay: 97.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₁H₂₂O₂.

2-Propylhexanoic Acid Ethyl Ester-d5, CAS: /, stock: 8.8g, assay: 97.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₁H₁₇D₅O₂.

2-Propylhexanoic Acid Methyl Ester, CAS: 5162-60-7, stock: 3.6g, assay: 96.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₀H₂₀O₂.

2-Propylhexanoic Acid Methyl Ester-d3, CAS: /, stock: 8.6g, assay: 96.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₀H₁₇D₃O₂.

2-Propylhexanoic Acid-d7, CAS: 1246818-01-8, stock: 4.5g, assay: 98.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₉H₁₁D₇O₂.

3-Hydroxy-2-propyl-4-pentenoic Acid Ethyl Ester(Mixture of diastereomers), CAS: 96107-27-6, stock: 9.7g, assay: 97.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₀H₁₈O₃.

Diallylacetic Acid, CAS: 99-67-2, stock: 2.3g, assay: 97.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₈H₁₂O₂.

Diallylacetic Acid Methyl Ester, CAS: 54385-33-0, stock: 5.1g, assay: 98.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₉H₁₄O₂.

Diallylacetic Acid Methyl-d3 Ester, CAS: /, stock: 3.4g, assay: 96%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₉H₁₁D₃O₂.

Diallylmalonic Acid, CAS: 4372-31-0, stock: 5.6g, assay: 96.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₉H₁₂O₄.

Ethyl 2-Propyl-4-pentenoate, CAS: 96107-26-5, stock: 4.6g, assay: 96.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₀H₁₈O₂.

Ethyl-d5 2-Propyl-4-pentenoate, CAS: /, stock: 7.8g, assay: 99%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₀H₁₃D₅O₂.

Methacetin, CAS: 51-66-1, stock: 7.8g, assay: 97.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₉H₁₁NO₂.

Methacetin-13C, CAS: 72156-70-8, stock: 8.2g, assay: 98.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₈¹³CH₁₁NO₂.

N2-Trityl-Valsartan Benzyl Ester, CAS: /, stock: 8.3g, assay: 98.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₅₀H₄₉N₅O₃.

trans-2-Methyl-2-pentenoic Acid, CAS: 16957-70-3, stock: 4g, assay: 97.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₆H₁₀O₂.

Valproic Acid β-D-Glucuronide, CAS: 60113-83-9, stock: 6.6g, assay: 96.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₄H₂₄O₈.

Valproic Acid β-D-Glucuronide Allyl Ester, CAS: /, stock: 9.7g, assay: 96.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₇H₂₈O₈.

Valproic Acid β-D-Glucuronide O-Propene Ester, CAS: /, stock: 8.1g, assay: 96%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₇H₂₈O₈.

Valsartan Acyl Glucuronide, CAS: /, stock: 6.2g, assay: 97.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₃₀H₃₇N₅O₉.

Valproic Acid-d15 β-D-Glucuronide, CAS: /, stock: 9.3g, assay: 98.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₄H₉D₁₅O₈.

Valproic Acid-d4, CAS: 87745-17-3, stock: 4.7g, assay: 96.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₈H₁₂D₄O₂.

Valproic Acid-d6 β-D-Glucuronide, CAS: /, stock: 1.7g, assay: 99%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₄H₁₈D₆O₈.

Valsartan N1-Glucuronide, CAS: /, stock: 1.1g, assay: 98.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₃₀H₃₇N₅O₉.

Valsartan N2-Glucuronide, CAS: /, stock: 8.2g, assay: 96.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₃₀H₃₇N₅O₉.

((2,3,5,6-Tetramethylphenyl)sulfonyl)valine, CAS: 1009595-18-9, stock: 2.1g, assay: 98.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₅H₂₃NO₄S.

((2,6-Dichlorophenyl)sulfonyl)valine, CAS: 1008267-76-2, stock: 1.2g, assay: 96.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₁H₁₃NO₄SCl₂.

((2-Fluorophenyl)sulfonyl)valine, CAS: 1009676-99-6, stock: 5.7g, assay: 96.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₁H₁₄NO₄FS.

((2R,5S,10aS,10bS)-10b-Hydroxy-5-isopropyl-2-methyl-3,6-dioxooctahydro-2H-oxazolo[3,2-a]pyrrolo[2,1-c]pyrazin-2-yl)carbamic Acid Benzyl Ester, CAS: /, stock: 5.6g, assay: 97.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₁H₂₇N₃O₆.

((3-Chlorophenyl)sulfonyl)valine, CAS: 1009549-57-8, stock: 1.6g, assay: 97%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₁H₁₄NO₄SCl.

Acetoxyvalerenic Acid, CAS: 84638-55-1, stock: 6.4g, assay: 98.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₇H₂₄O₄.

Hydroxyvalerenic Acid, CAS: 1619-16-5, stock: 8.2g, assay: 96.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₅H₂₂O₃.

(2R,4S)-1-(tert-Butoxycarbonyl)-4-(methoxymethyl)pyrrolidine-2-carboxylic Acid, CAS: /, stock: 3g, assay: 96.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₂H₂₁NO₅.

(2S)-2-Cyclohexyl-N-(2-pyrazinylcarbonyl)glycyl-3-methyl-d-valine, CAS: 1033882-31-3, stock: 4.8g, assay: 96.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₉H₂₈N₄O₄.

(2S)-2-Cyclohexyl-N-(2-pyrazinylcarbonyl)glycyl-3-methyl-L-valine, CAS: 402958-96-7, stock: 7.6g, assay: 97.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₉H₂₈N₄O₄.

(2S,3S,5S)-2-Amino-3-hydroxy-1,6-diphenylhexane-5-N-carbamoyl-L-valine Amide, CAS: 1356922-07-0, stock: 2.3g, assay: 98.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₄H₃₄N₄O₃.

(R)-3-Hydroxyisobutyric Acid Potassium Salt, CAS: 1402046-49-4, stock: 5.9g, assay: 96.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₄H₇KO₃.

(S)-2-(Benzyloxy)-3-((3S,8aS)-3-isopropyl-1,4-dioxohexahydropyrrolo[1,2-a]pyrazin-2(1H)-yl)-2-methyl-3-oxopropanoic Acid Ethyl Ester, CAS: /, stock: 8.5g, assay: 98.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₃H₃₀N₂O₆.

(S)-3-Hydroxyisobutyric Acid Potassium Salt, CAS: 1402163-95-4, stock: 1.2g, assay: 98.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₄H₇KO₃.

(S)-Methyl 2-(Ethylamino)-3-methylbutanoate, CAS: 222550-60-9, stock: 1.3g, assay: 98.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₈H₁₇NO₂.

(S)-N-(Benzyloxycarbonyl)-N-methylvaline, CAS: 42417-65-2, stock: 8.4g, assay: 98%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₄H₁₉NO₄.

3-Fluoro-DL-valine, CAS: 43163-94-6, stock: 5.7g, assay: 98.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₅H₁₀FNO₂.

5-Fluoro ADB (1.0 mg/mL in Acetonitrile), CAS: 1971007-89-2, stock: 7.4g, assay: 96.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₀H₂₈FN₃O₃.

1-Hydroxy Valdecoxib, CAS: 181695-81-8, stock: 3.2g, assay: 97.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₆H₁₄N₂O₄S.

1-Hydroxy Valdecoxib-13C2,15N, CAS: 1346601-29-3, stock: 1.5g, assay: 96.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₄¹⁵C₂H₁₄N¹⁵NO₄S.

5-Fluoro-MDMB-PICA, CAS: 1971007-88-1, stock: 8.8g, assay: 96.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₁H₂₉FN₂O₃.

4,5-Dihydro-5-methyl-3,4-diphenyl-5-isoxazolol, CAS: 181696-73-1, stock: 8.6g, assay: 96.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₆H₁₅NO₂.

Acetyl Pepstatin, CAS: 11076-29-2, stock: 8.1g, assay: 97.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₃₁H₅₇N₅O₉.

4,5-Dihydro-5-methyl-3,4-diphenyl-5-isoxazolol-13C2, 15N, CAS: 1189468-68-5, stock: 3.2g, assay: 98.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₄¹³C₂H₁₅¹⁵NO₂.

4-Sulfamoylphenylboronic Acid Pinacol Ester, CAS: 214360-51-7, stock: 4.3g, assay: 96.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₂H₁₈BNO₄S.

Methyl Chloroacetate, CAS: 96-34-4, stock: 4g, assay: 98.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₃H₅ClO₂.

AMB, CAS: 1890250-13-1, stock: 4.8g, assay: 98.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₉H₂₇N₃O₃.

Angiotensin Acetate, CAS: 20071-00-5, stock: 2g, assay: 98.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₄₉H₇₀N₁₄O₁₁ • 2(C ₂H₄O₂).

Benzoyl-dl-valine, CAS: 2901-80-6, stock: 6.9g, assay: 98.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₂H₁₅NO₃.

Valdecoxib Dimer, CAS: 1373038-60-8, stock: 9.7g, assay: 98.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₃₂H₂₅N₃O₆S₂.

Valdecoxib Sulfonic Acid, CAS: 181696-35-5, stock: 5.1g, assay: 97.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₆H₁₃NO₄S.

(2S,3S)-2-Isocyanato-3-methylvaleric Acid Methyl Ester, CAS: 120219-17-2, stock: 4.4g, assay: 97.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₈H₁₃NO₃.

Valdecoxib Sulfonic Acid-13C2,15N, CAS: 1391053-52-3, stock: 2.4g, assay: 96.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₄¹³C₂H₁₃¹⁵NO₄S.

Valdecoxib Sulfonyl Chloride, CAS: 509074-26-4, stock: 1.4g, assay: 98.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₆H₁₂ClNO₃S.

Valdecoxib Sulfonyl Chloride-13C2,15N, CAS: 1391051-92-5, stock: 3.6g, assay: 98.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₄¹³C₂H₁₂Cl¹⁵NO₃S.

Boc-D-Pen(pMeBzl)-OH . DCHA, CAS: 198470-36-9, stock: 8.3g, assay: 97.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₈H₂₇NO₄S  • C₁₂H₂₃N.

(S)-(-)-2-Isocyanato-4-methylvaleric Acid Methyl Ester, CAS: 39570-63-3, stock: 5.9g, assay: 96.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₈H₁₃NO₃.

Boc-L-Norvaline DCHA, CAS: 67861-96-5, stock: 2.5g, assay: 98.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₂H₂₃N  •  C₁₀H₁₉NO₄.

(S)-2-Chloro-4-methyl-N-valeric Acid, CAS: 28659-81-6, stock: 6.8g, assay: 96.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₆H₁₁ClO₂.

Boc-L-Valine Amide, CAS: 35150-08-4, stock: 9g, assay: 98%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₀H₂₀N₂O₃.

BPC 157, CAS: 137525-51-0, stock: 7.2g, assay: 98%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₆₂H₉₈N₁₆O₂₂.

Bromo(2-methylpropyl)magnesium, CAS: 926-62-5, stock: 2.7g, assay: 98.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₄H₉BrMg.

Chloroacetyl-dl-norvaline, CAS: 6940-47-2, stock: 9.8g, assay: 98.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₇H₁₂ClNO₃.

Concanavalin A, CAS: 11028-71-0, stock: 3.8g, assay: 98.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  N/A.

2-Bromovaleric acid, CAS: 584-93-0, stock: 2.8g, assay: 96.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₅H₉BrO₂.

D-​Valine-​2,​3,​4,​4,​4,​4’,​4’,​4’-​d8, CAS: 1116448-82-8, stock: 9.9g, assay: 96.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₅H₃D₈NO₂.

2-Ethyl-2-methylsuccinic Acid, CAS: 631-31-2, stock: 5.6g, assay: 97.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₇H₁₂O₄.

2-Ethyl-4-methyl-pentyl Salicylate, CAS: /, stock: 2.6g, assay: 97.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₅H₂₂O₃.

D-Boc Valine Methyl Ester, CAS: 106391-85-9, stock: 7.6g, assay: 98.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₁H₂₁NO₄.

D-Norvaline, CAS: 09/12/2013, stock: 9.7g, assay: 97.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₅H₁₁NO₂.

2-Oxovaleric Acid, CAS: 1821-02-9, stock: 8.4g, assay: 97.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₅H₈O₃.

D-Valine tert-Butyl Ester Hydrochloride, CAS: 104944-18-5, stock: 1.3g, assay: 96.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₉H₂₀ClNO₂.

Des(N-methoxycarbonyl)-L-valine) Velpatasvir, CAS: /, stock: 9.2g, assay: 96.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₄₂H₄₃N₇O₅.

dl-3-Methylvaline hydrochloride, CAS: 93667-66-4, stock: 5.5g, assay: 98.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₆H₁₄ClNO₂.

DL-Alanyl-DL-valine, CAS: 1999-46-8, stock: 6.4g, assay: 97.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₈H₁₆N₂O₃.

DL-AP5 Sodium Salt, CAS: 1303993-72-7, stock: 9g, assay: 96.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₅H₁₁NNaO₅P.

Dl-Leucyl-Dl-Valine, CAS: 35436-83-0, stock: 3g, assay: 98.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₁H₂₂N₂O₃.

4-Hydroxy-2-oxovaleric Acid-d4 Potassium Salt, CAS: /, stock: 9.2g, assay: 98.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₅H₄D₄KO₄.

4-Methyl-2-oxovaleric Acid, CAS: 816-66-0, stock: 1.2g, assay: 98.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₆H₁₀O₃.

Dl-valine, CAS: 516-06-3, stock: 7.6g, assay: 96.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₅H₁₁NO₂.

DL-Valine Methyl Ester Hydrochloride, CAS: 06/05/5619, stock: 9.3g, assay: 98.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₆H₁₄ClNO₂.

Enniatin B2, CAS: 632-91-7, stock: 4.8g, assay: 97.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₃₂H₅₅N₃O₉.

4-Methylpentanoyl Chloride, CAS: 38136-29-7, stock: 8g, assay: 96.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₆H₁₁ClO.

Ethyl (2S,5S)-5-methylpyrrolidine-2-carboxylate, CAS: 676560-84-2, stock: 6.4g, assay: 97.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₈H₁₅NO₂.

Fmoc-D-Pen(Acm)-OH, CAS: 201531-77-3, stock: 5g, assay: 97.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₃H₂₆N₂O₅S.

Fmoc-L-beta-homovaline, CAS: 172695-33-9, stock: 6.7g, assay: 98.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₁H₂₃NO₄.

Fmoc-n-methyl-d-valine, CAS: 103478-58-6, stock: 5.6g, assay: 97.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₁H₂₃NO₄.

3,8-Dihydroxy-9-methoxy-6H-Dibenzo[b,d]pyran-6-one, CAS: 1006683-96-0, stock: 3.4g, assay: 98.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₄H₁₀O₅.

8,9-di-O-Methyl-urolithin C, CAS: 126438-35-5, stock: 1.8g, assay: 98.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₅H₁₂O₅.

8,9-Di-O-methyl-urolithin D, CAS: 1192835-55-4, stock: 5.5g, assay: 97.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₅H₁₂O₆.

8,9-Di-O-methyl-urolithin D-d6, CAS: /, stock: 7.1g, assay: 98.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₅H₆D₆O₆.

5-(4-Fluorophenoxy)valeric Acid, CAS: 347867-75-8, stock: 6.6g, assay: 98.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₁H₁₃O₃F.

5-(4-Fluorophenyl)valeric Acid, CAS: 24484-22-8, stock: 2g, assay: 98.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₁H₁₃O₂F.

Fructose Valine (mixture of diastereomers), CAS: 10003-64-2, stock: 1.5g, assay: 96.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₁H₂₁NO₇.

FV 100 (free base), CAS: 956483-02-6, stock: 6.8g, assay: 98.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₇H₃₅N₃O₆.

8-O-Methyl-urolithin C, CAS: 713519-19-8, stock: 7.1g, assay: 98.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₄H₁₀O₅.

Isourolithin A, CAS: 174023-48-4, stock: 5g, assay: 98.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₃H₈O₄.

5-(Carbobenzoxyamino)valeric Acid, CAS: 23135-50-4, stock: 1.2g, assay: 97.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₃H₁₇NO₄.

FV 100 N-Fmoc, CAS: 1269409-87-1, stock: 1.9g, assay: 97.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₄₂H₄₅N₃O₈.

FV 100 N-Fmoc-d7, CAS: /, stock: 6.4g, assay: 97.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₄₂H₃₈D₇N₃O₈.

Isourolithin A 9-Glucuronide, CAS: 1268248-75-4, stock: 2.4g, assay: 96.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₉H₁₆O₁₀.

Isourolithin B Glucuronide, CAS: 1268248-72-1, stock: 1g, assay: 97.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₉H₁₆O₁₀.

FV 100-d7 (Major), CAS: /, stock: 3.5g, assay: 97.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₇H₂₈D₇N₃O₆.

Glycyl-D-valine, CAS: 10521-49-0, stock: 2g, assay: 98.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₇H₁₄N₂O₃.

Urolithin A Glucuronide, CAS: 1365982-52-0, stock: 4g, assay: 98%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₉H₁₆O₁₀.

5-Aminovaleric Acid Hydroiodide (Low water content), CAS: 1705581-28-7, stock: 4.8g, assay: 98.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₅H₁₁NO₂ • HI.

Glycyl-DL-norvaline, CAS: 2189-27-7, stock: 5g, assay: 97.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₇H₁₄N₂O₃.

Glycyl-l-valine, CAS: 1963-21-9, stock: 4.9g, assay: 98.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₇H₁₄N₂O₃.

Urolithin B Glucuronide, CAS: 823806-74-2, stock: 3.7g, assay: 98.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₉H₁₆O₉.

H-Ala-val-oh, CAS: 3303-45-5, stock: 9.1g, assay: 96.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₈H₁₆N₂O₃.

H-VAL-VAL-OH, CAS: 3918-94-3, stock: 4.2g, assay: 97%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₀H₂₀N₂O₃.

Urolithin C, CAS: 165393-06-6, stock: 8.4g, assay: 98.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₃H₈O₅.

Hexafluoro-DL-valine, CAS: 16063-80-2, stock: 5.3g, assay: 97.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₅H₅NO₂F₆.

Urolithin D, CAS: 131086-98-1, stock: 8.2g, assay: 98%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₃H₈O₆.

Urolithin E, CAS: 1453297-45-4, stock: 2.6g, assay: 98.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₃H₈O₆.

Urolithin M5, CAS: 91485-02-8, stock: 2g, assay: 97.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₃H₈O₇.

5-Mercaptovaleric Acid, CAS: 30247-98-4, stock: 6.7g, assay: 96.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₅H₁₀O₂S.

Urolithin M6, CAS: 1006683-97-1, stock: 7.2g, assay: 99%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₃H₈O₆.

Urolithin M7, CAS: 531512-26-2, stock: 9.4g, assay: 96.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₃H₈O₅.

Iso Cyclosporin A, CAS: 59865-16-6, stock: 4.9g, assay: 98.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₆₂H₁₁₁N₁₁O₁₂.

Iso Cyclosporin H Trifluoroacetic Acid Salt, CAS: /, stock: 4.8g, assay: 96.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₆₂H₁₁₁N₁₁O₁₂ • x( C₂HF₃O₂).

α-Methyl-D-valine, CAS: 53940-82-2, stock: 3.9g, assay: 97.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₆H₁₃NO₂.

α-Methyl-L-valine, CAS: 53940-83-3, stock: 2.3g, assay: 98.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₆H₁₃NO₂.

L-Allysine, CAS: 09/12/6665, stock: 2.3g, assay: 96.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₆H₁₁NO₃.

Eflornithine Hydrochloride Monohydrate, CAS: 96020-91-6, stock: 7.4g, assay: 98.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₆H₁₅ClF₂N₂O₃.

Eflornithine-d6 Hydrochloride Monohydrate, CAS: /, stock: 7.9g, assay: 96.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₆H₉D₆ClF₂N₂O₃.

Ethyl 2,2-Diisobutyl-3-methyl-3-oxopropionate, CAS: 412027-13-5, stock: 9.1g, assay: 97.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₄H₂₆O₃.

L-Norvaline, CAS: 6600-40-4, stock: 2.5g, assay: 96.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₅H₁₁NO₂.

L-Norvaline Ethyl Ester Hydrochloride, CAS: 40918-51-2, stock: 9.2g, assay: 98.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₇H₁₅NO₂ • (HCl).

L-Norvaline t-Butyl Ester Hydrochloride, CAS: 119483-47-5, stock: 7.8g, assay: 97.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₉H₁₉NO₂ • HCl.

Isovaleryl Chloride, CAS: 108-12-3, stock: 8.3g, assay: 97.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₅H₉ClO.

1,3-Diaminotetrafluorobenzene, CAS: 1198-63-6, stock: 4.2g, assay: 96.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₆H₄F₄N₂.

1,4-Butane-1,1,2,2,3,3,4,4-d8-diamine, CAS: 709608-92-4, stock: 6.3g, assay: 97.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₄H₄D₈N₂.

L-Valine Benzyl Ester, CAS: 21760-98-5, stock: 1.9g, assay: 98.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₂H₁₇NO₂.

L-Valine Benzyl Ester Hydrochloride, CAS: 2462-34-2, stock: 1.2g, assay: 98.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₂H₁₈ClNO₂.

1,4-Diaminobutane, CAS: 110-60-1, stock: 9.8g, assay: 96%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₄H₁₂N₂.

1,4-Diaminobutane Dihydrochloride, CAS: 333-93-7, stock: 1.3g, assay: 98.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₄H₁₄Cl₂N₂.

L-Valine Chloromethyl Ketone Hydrochloride, CAS: 107831-79-8, stock: 3.3g, assay: 98.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₆H₁₂ClNO  •  HCl.

L-Valine Ethyl Ester Hydrochloride, CAS: 17609-47-1, stock: 5.8g, assay: 97.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₇H₁₅NO₂ • HCl.

1,4-Diaminobutane-13C4, CAS: 1173023-66-9, stock: 8.8g, assay: 96.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  ¹³C₄H₁₂N₂.

1,8-Octanediol, CAS: 629-41-4, stock: 5.9g, assay: 97.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₈H₁₈O₂.

γ-Valprolactone, CAS: 40923-58-8, stock: 4.4g, assay: 97.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₈H₁₄O₂.

L-Valine tert-Butyl Ester Hydrochloride, CAS: 13518-40-6, stock: 6.7g, assay: 96.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₉H₂₀ClNO₂.

1-[[4-(1-Methylethoxy)phenyl]sulfonyl]-4-(phenylmethoxy)-benzene-d7, CAS: /, stock: 8.1g, assay: 98.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₂H₁₅D₇O₄S.

1H,1H,11H-Eicosafluoro-1-undecanol, CAS: 307-70-0, stock: 1.2g, assay: 96.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₁H₄F₂₀O.

L-Citrulline, CAS: 372-75-8, stock: 4.6g, assay: 96.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₆H₁₃N₃O₃.

L-Citrulline-13C5, CAS: /, stock: 8g, assay: 98.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C¹³C₅H₁₃N₃O₃.

2,3-O-Isopropylidene-L-gulonolactone, CAS: 94840-08-1, stock: 1g, assay: 97.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₉H₁₄O₆.

2,4,6,8,10-Pentamethylcyclopentasiloxane, CAS: 6166-86-5, stock: 6.5g, assay: 97%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₅H₂₀O₅Si₅.

L-Citrulline-d6, CAS: 1331908-61-2, stock: 7.7g, assay: 97.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₆H₇D₆N₃O₃.

L-Citrulline-d7, CAS: /, stock: 3.8g, assay: 99%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₆H₆D₇N₃O₃.

N,N-Bis[(1,1-dimethylethoxy)carbonyl]-5-oxo-L-norvaline 1,1-Dimethylethyl Ester, CAS: 129241-89-0, stock: 1.5g, assay: 96.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₉H₃₃NO₇.

N,N-Dimethyl-L-valine, CAS: 67368-47-2, stock: 3.9g, assay: 97.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₇H₁₅NO₂.HCl.

N-((N-Methyl-N-((2-isopropyl-4-thiazolyl)methyl)amino)carbonyl)-L-valine Lithium Salt, CAS: 201409-23-6, stock: 8.5g, assay: 96.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₄H₂₂LiN₃O₃S.

N-(2,4-Dinitrophenyl)-L-valine, CAS: 1694-97-9, stock: 6g, assay: 98.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₁H₁₃N₃O₆.

Acetylurethane, CAS: 2597-54-8, stock: 3.6g, assay: 97.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₅H₉NO₃.

N-(2-Cyanoethyl)-L-valine, CAS: 51078-49-0, stock: 2.3g, assay: 98.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₈H₁₄N₂O₂.

N-(2-Cyanoethyl-d3)-L-valine, CAS: 160210-22-0, stock: 2.1g, assay: 96.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₈H₁₁D₃N₂O₂.

(2R)-Sorbitan Monolauric Acid Ester, CAS: /, stock: 5.7g, assay: 97.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₈H₃₆O₇.

Benzyl Vinylcarbamate, CAS: 84713-20-2, stock: 7.2g, assay: 96.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₀H₁₁NO₂.

(2R)-Sorbitan Monolauric Acid Ester-d22 (Major), CAS: /, stock: 2.8g, assay: 97.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₈H₁₄D₂₂O₇.

Diisononyl Adipate (mixture of isomers), CAS: 33703-08-1, stock: 4.4g, assay: 96.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₄H₄₆O₄.

1,3,5-Tris(2-hydroxyethyl)cyanuric Acid, CAS: 839-90-7, stock: 9.3g, assay: 97.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₉H₁₅N₃O₆.

N-(Methoxycarbonyl)-3-methyl-D-valine, CAS: 1191091-65-2, stock: 3.9g, assay: 96.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₈H₁₅NO₄.

1,3,5-Tris(2-hydroxyethyl)cyanuric Acid-15N3, CAS: /, stock: 3.9g, assay: 96.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₉H₁₅¹⁵N₃O₆.

Diurethane Dimethacrylate(Mixture of Isomers), CAS: 72869-86-4, stock: 7.6g, assay: 98.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₃H₃₈N₂O₈.

Hexafluoropropene Dimer, CAS: 13429-24-8, stock: 5.9g, assay: 97.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  (C₃F₆)₂.

N-2-Nitrophenylsulfenyl-L-valine Dicyclohexylammonium Salt, CAS: 7675-57-2, stock: 7g, assay: 97.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₁H₁₄N₂O₄S.C₁₂H₂₃N.

1,3-Diethylbarbituric Acid, CAS: 32479-73-5, stock: 4.9g, assay: 96.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₈H₁₂N₂O₃.

Hydroxyurethane, CAS: 589-41-3, stock: 4.1g, assay: 98.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₃H₇NO₃.

N-4-Quinazolinylnorvaline, CAS: 1008675-41-9, stock: 9.8g, assay: 96.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₃H₁₅N₃O₂.

N-Acetyl-D-Valine, CAS: 17916-88-0, stock: 9.1g, assay: 96.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₇H₁₃NO₃.

N-Acetyl-DL-norvaline, CAS: 7682-15-7, stock: 4.1g, assay: 98.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₇H₁₃NO₃.

1,3:2,4-Bis-O-[(4-methylphenyl)methylene]-D-glucitol 1-Dodecanoate-d22, CAS: /, stock: 5.5g, assay: 97.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₃₄H₂₆D₂₂O₇.

(3β,5α)5,8-[N,N-(4-Phenylurazole)]-3-O-acetyl-cholest-6,22-diene-3-ol, CAS: 60324-76-7, stock: 2.1g, assay: 98.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₃₈H₅₁N₃O₄.

Methylene Diurethane, CAS: 3693-53-6, stock: 8.4g, assay: 97.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₇H₁₄N₂O₄.

N,N-Dichlorourethane, CAS: 13698-16-3, stock: 3.1g, assay: 96.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₃H₅NO₂Cl₂.

N-Acetyl-L-valine, CAS: 96-81-1, stock: 4.5g, assay: 97.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₇H₁₃NO₃.

(3β,5α)5,8-[N,N-(4-Phenylurazole)]-cholest-6,22-diene-3,25-diol-d6, CAS: /, stock: 7.7g, assay: 98%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₃₆H₄₃D₆N₃O₄.

(3β,5α,8α)-5,8-[N,N-(4-Phenylurazole)]-3-O-tert-butyldimethylsilyl-6-dehydro-desmostanol-d6, CAS: /, stock: 5g, assay: 97.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₄₁H₅₅D₆N₃O₃Si.

N-(2-Bromoethyl)urethane, CAS: 7452-78-0, stock: 8.4g, assay: 98.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₅H₁₀BrNO₂.

N-Benzyloxycarbonyl D-Valine Methyl Ester, CAS: 154674-67-6, stock: 4.2g, assay: 96.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₄H₁₉NO₄.

(3β,5α,8α,22E)-5,8-[N,N-(4-Phenylurazole)]-ergosta-6,22-diene-3,24,25-triol 3-Acetate, CAS: /, stock: 5.1g, assay: 96.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₃₈H₅₁N₃O₆.

(3β,5α,8α,22E)-5,8-[N,N-(4-Phenylurazole)]-ergosta-6,22-diene-3,24,25-triol-d3 3-Acetate, CAS: /, stock: 7.7g, assay: 96.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₃₈H₄₈D₃N₃O₆.

N-(p-Chlorophenyl)urethane, CAS: 2621-80-9, stock: 10g, assay: 98.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₉H₁₀NO₂Cl.

N-(tert-Butoxycarbonyl)aniline, CAS: 03/01/3422, stock: 1.4g, assay: 97.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₁H₁₅NO₂.

N-Boc-3-ethyl L-Norvaline, CAS: 35264-04-1, stock: 8.5g, assay: 97.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₂H₂₃NO₄.

N-(tert-Butoxycarbonyl)aniline-13C6, CAS: 176850-21-8, stock: 6.1g, assay: 96.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₅¹³C₆H₁₅NO₂.

N-Boc-L-lysine, CAS: 13734-28-6, stock: 4.9g, assay: 96.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₁H₂₂N₂O₄.

SKF-525A Hydrochloride, CAS: 62-68-0, stock: 2.4g, assay: 97.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₃H₃₂ClNO₂.

N-Boc-L-valine N’-methoxy-N’-methylamide, CAS: 87694-52-8, stock: 2.1g, assay: 96.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₂H₂₄N₂O₄.

1-Methyluric Acid, CAS: 708-79-2, stock: 9.7g, assay: 96.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₆H₆N₄O₃.

N-Cyanoacetylurethane, CAS: 05/04/6629, stock: 2.1g, assay: 96.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₆H₈N₂O₃.

N-Methyl-N-nitrosourethane, CAS: 615-53-2, stock: 9.9g, assay: 96.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₄H₈N₂O₃.

Trimethyl Orthovalerate, CAS: 13820-09-2, stock: 9.8g, assay: 96.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₈H₁₈O₃.

N-Boc-L-valine-O-nitrophenyl Ester, CAS: 41120-72-3, stock: 8.9g, assay: 98.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₆H₂₂N₂O₆.

1-Methyluric Acid-d3, CAS: 1189480-64-5, stock: 3.9g, assay: 97.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₆H₃D₃N₄O₃.

Valeraldehyde(Pentanal), CAS: 110-62-3, stock: 2.4g, assay: 98.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₅H₁₀O.

N-Carbobenzoxy-DL-norvaline, CAS: 21691-43-0, stock: 9.2g, assay: 98.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₃H₁₇NO₄.

11-Hydroxylauric Acid, CAS: 32459-66-8, stock: 6.6g, assay: 98.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₂H₂₄O₃.

4-(3-Pyridyl)-1,2,4-triazolodone-3,5-dione, CAS: 1076199-39-7, stock: 2.8g, assay: 98.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₇H₆N₄O₂.

Phenyl Mercury Neodecanoate, CAS: 26545-49-3, stock: 1.4g, assay: 98.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₆H₂₄HgO₂.

Phenylmercuric Octanoate, CAS: 13864-38-5, stock: 5.8g, assay: 96.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₄H₂₀HgO₂.

N-Carbobenzoxy-L-valine Succinimidyl Ester, CAS: 05/11/3496, stock: 2.7g, assay: 98.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₇H₂₀N₂O₆.

4-Methylurazole, CAS: 16312-79-1, stock: 2.6g, assay: 96.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₃H₅N₃O₂.

4-[4-(Dimethylamino)naphthyl]-1,2,4-triazolidine-3,5-dione, CAS: 1346604-81-6, stock: 9.3g, assay: 99%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₄H₁₄N₄O₂.

4-[4-(Dimethylamino)phenyl]-1,2,4-triazolidine-3,5-dione, CAS: 883455-55-8, stock: 5.9g, assay: 96.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₀H₁₂N₄O₂.

Potassium Neodecanoate, CAS: 26761-42-2, stock: 2.5g, assay: 98%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₀H₁₉KO₂.

5α,8α-[N,N-(4-Phenylurazole)]-3-O-tert-butyldimethylsilyl-chol-6-en-24-al-3β-ol, CAS: /, stock: 8g, assay: 96.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₃₈H₅₅N₃O₄Si.

rac-2-​Butene-​1,​4-​diol, CAS: 110-64-5, stock: 8.9g, assay: 96.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₄H₈O₂.

Sodium 2-((2-Aminoethyl)amino)ethanesulfonate, CAS: 34730-59-1, stock: 6.7g, assay: 98.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₄H₁₁N₂NaO₃S.

N-Carboxybenzyl Valbenazine, CAS: 1025504-76-0, stock: 2.4g, assay: 97.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₃₂H₄₄N₂O₆.

5α,8α-[N,N-(4-Phenylurazole)]-3-O-tert-butyldimethylsilyl-chol-6-en-3β,24-diol, CAS: /, stock: 9.2g, assay: 96.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₃₈H₅₇N₃O₄Si.

5α,8α-[N,N-(4-Phenylurazole)]-3-O-tert-butyldimethylsilyl-cholest-7-ene-3β,24-diol-d7, CAS: /, stock: 6.1g, assay: 96.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₄₁H₅₆D₇N₃O₄Si.

N-Chloroacetyl-DL-valine, CAS: 4090-17-9, stock: 4.3g, assay: 98.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₇H₁₂NO₃Cl.

5α,8α-[N,N-(4-Phenylurazole)]-3β-O-tert-butyldimethylsilyloxy-chol-6-en-24-oic Acid Methyl Ester, CAS: /, stock: 6.6g, assay: 98.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₃₉H₅₇N₃O₅Si.

trans-2-Butene-1,4-diol, CAS: 821-11-4, stock: 6.8g, assay: 98%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₄H₈O₂.

Trimethylolpropane Tris(2-methyl-1-aziridinepropionate), CAS: 64265-57-2, stock: 5.7g, assay: 96.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₄H₄₁N₃O₆.

N-Chloroacetyl-L-valine, CAS: 2279-16-5, stock: 3.4g, assay: 98.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₇H₁₂ClNO₃.

N-Ethoxycarbonyl α-Methyl-L-valine, CAS: 952577-51-4, stock: 4.4g, assay: 97.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₉H₁₇NO₄.

2-Demethoxy-2-chloro Urapidil, CAS: 34661-73-9, stock: 4.6g, assay: 96.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₉H₂₆ClN₅O₂.

2-Demethoxy-2-chloro Urapidil-d4, CAS: 1794883-40-1, stock: 9.7g, assay: 96.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₉H₂₂D₄ClN₅O₃.

N-Fmoc-D-valine, CAS: 84624-17-9, stock: 8.8g, assay: 97%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₀H₂₁NO₄.

2-Demethoxy-4-methoxy Urapidil, CAS: 34661-79-5, stock: 1g, assay: 97.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₀H₂₉N₅O₃.

2-Demethoxy-4-methoxy Urapidil-d4, CAS: 1794780-14-5, stock: 9.9g, assay: 98.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₀H₂₅D₄N₅O₃.

N-Formyl-l-valine, CAS: 4289-97-8, stock: 3.3g, assay: 97.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₆H₁₁NO₃.

2-Chloro-4-nitropyridine, CAS: 23056-36-2, stock: 3.4g, assay: 97.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₅H₃ClN₂O₂.

4-Hydroxy Urapidil, CAS: 88733-12-4, stock: 8.4g, assay: 96.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₀H₂₉N₅O₄.

5-Methylurapidil, CAS: 34661-85-3, stock: 8.1g, assay: 98.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₁H₃₁N₅O₃.

N-Me-nva-oh hydrochloride, CAS: 1899809-55-2, stock: 8.9g, assay: 98.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₆H₁₃NO₂.

Furamide, CAS: 3736-81-0, stock: 3.4g, assay: 96.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₄H₁₁Cl₂NO₄.

O-Desmethyl Urapidil, CAS: 91453-03-1, stock: 7.5g, assay: 98.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₉H₂₇N₅O₃.

N-Methyl-dl-valine hydrochloride, CAS: 2566-32-7, stock: 3.4g, assay: 98.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₆H₁₃NO₂ • HCl.

O-Desmethyl Urapidil-d4, CAS: /, stock: 6.4g, assay: 96.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₉H₂₃D₄N₅O₃.

Urapidil, CAS: 34661-75-1, stock: 3.5g, assay: 97.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₀H₂₉N₅O₃.

N-Phenoxycarbonyl-L-valine, CAS: 126147-70-4, stock: 7.8g, assay: 99%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₂H₁₅NO₄.

N-Phenoxycarbonyl-L-valine-2,3,4,4,4,5,5,5-d8, CAS: /, stock: 5.4g, assay: 96.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₂H₇D₈NO₄.

2-Isopropylpyridin-4-yl-boronic Acid Pinacol Ester, CAS: 1352796-58-7, stock: 1.3g, assay: 97.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₄H₂₂BNO₂.

2-Methyloxazolo[5,4-d]pyrimidine-5,7(4H,6H)-dione, CAS: 1015697-99-0, stock: 4.3g, assay: 96.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₆H₅N₃O₃.

Urazole, CAS: 3232-84-6, stock: 8.4g, assay: 96.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂H₃N₃O₂.

N-[(9Z)-1-Oxo-9-octadecenyl]-L-valine, CAS: 60374-41-6, stock: 1.5g, assay: 98.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₃H₄₃NO₃.

N-[(Benzyloxy)carbonyl]-5-chloro-5-hydroxy-L-norvaline 1,1-Dimethylethyl Ester, CAS: /, stock: 4.8g, assay: 97.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₇H₂₄ClNO₅.

N-[1-Deoxy-2,3:4,5-bis-O-(1-methylethylidene)-β-D-fructopyranos-1-yl]-L-valine, CAS: 114669-91-9, stock: 8.5g, assay: 98.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₇H₂₉NO₇.

3-Amino-3-oxo-propanoic Acid Phenylmethyl Ester, CAS: 1042348-44-6, stock: 6.5g, assay: 98.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₀H₁₁NO₃.

N-[[1-(Cyclohexylmethyl)-1H-indazol-3-yl]carbonyl]-3-methyl-L-valine, CAS: 1185889-12-6, stock: 7.9g, assay: 97%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₁H₂₉N₃O₃.

3-Hydroxylauric Acid, CAS: 1883-13-2, stock: 5.8g, assay: 97.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₂H₂₄O₃.

4,​6-​Dichloro-​3-​methylpyridazine, CAS: 68240-43-7, stock: 3.2g, assay: 97.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₅H₄Cl₂N₂.

4,​6-​Dimethoxy-1,​3,​5-​triazin-​2(1H)​-​one, CAS: 1075-59-8, stock: 4.8g, assay: 98.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₅H₇N₃O₃.

Orfamide A, CAS: 939960-34-6, stock: 9.6g, assay: 96.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₆₄H₁₁₄N₁₀O₁₇.

Orfamide B, CAS: 939960-35-7, stock: 2.6g, assay: 97.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₆₃H₁₁₂N₁₀O₁₇.

4-Hydroxy Nonenal Mercapturic Acid, CAS: 146764-24-1, stock: 7.9g, assay: 97.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₄H₂₅NO₅S.

4-Hydroxy Nonenal Mercapturic Acid-d3, CAS: /, stock: 6.4g, assay: 96.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₄H₂₂D₃NO₅S.

PEN (mouse), CAS: 1236955-25-1, stock: 6.3g, assay: 97.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₀₂ H₁₆₉ N₂₇ O₃₄.

Picolinoylvaline, CAS: 1160854-50-1, stock: 6.3g, assay: 97.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₁H₁₄N₂O₃.

4-Hydroxy-3-oxobutyl Mercapturic Acid, CAS: 716305-13-4, stock: 5.1g, assay: 98.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₉H₁₅NO₅S.

Romidepsin, CAS: 128517-07-7, stock: 7g, assay: 98.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₄H₃₆N₄O₆S₂.

Romidepsin-d8, CAS: /, stock: 2.6g, assay: 97.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₄H₂₈D₈N₄O₆S₂.

5,5-Dibromobarbituric Acid, CAS: 511-67-1, stock: 7.4g, assay: 98.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₄H₂Br₂N₂O₃.

5,5-dichloro-Barbituric acid, CAS: 699-40-1, stock: 2.7g, assay: 96.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₄H₂Cl₂N₂O₃.

5,5-Diethyl-1,3-diphenyl-2-iminobarbituric Acid, CAS: 200116-26-3, stock: 4.8g, assay: 96.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₀H₂₁N₃O₂.

5,5-Dipropylbarbituric Acid, CAS: 05/08/2217, stock: 7.9g, assay: 96.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₀H₁₆N₂O₃.

Sandramycin, CAS: 100940-65-6, stock: 7.4g, assay: 96.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₆₀H₇₆N₁₂O₁₆.

5-(sec-Pentyl)barbituric Acid, CAS: 83-29-4, stock: 6.5g, assay: 97.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₉H₁₄N₂O₃.

Urantide, CAS: 669089-53-6, stock: 9g, assay: 98%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₅₁H₆₆N₁₀O₁₂S₂.

Val-cit-PAB-OH, CAS: 159857-79-1, stock: 5.1g, assay: 97.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₈H₂₉N₅O₄.

5-Butylbarbituric Acid, CAS: 1953-33-9, stock: 6g, assay: 98.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₈H₁₂N₂O₃.

Valbenazine, CAS: 1025504-45-3, stock: 4.3g, assay: 97.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₄H₃₈N₂O₄.

5-chloro-Barbituric acid, CAS: 19645-77-3, stock: 9.9g, assay: 98.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₄H₃ClN₂O₃.

5-Desallyl 5-(2-Hydroxypropyl) Secobarbital, CAS: 33841-18-8, stock: 9.9g, assay: 96.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₂H₂₀N₂O₄.

5-Ethylbarbituric Acid, CAS: 2518-72-1, stock: 7.9g, assay: 97.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₆H₈N₂O₃.

Valine Ethyl Ester, Hydrochloride, CAS: 23358-42-1, stock: 6.4g, assay: 98.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₇H₁₆ClNO₂.

5-Nitrobarbituric Acid, CAS: 480-68-2, stock: 4.4g, assay: 98.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₄H₃N₃O₅.

Valspodar, CAS: 121584-18-7, stock: 5g, assay: 97.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₆₃H₁₁₁N₁₁O₁₂.

5-sec-Butylbarbituric Acid, CAS: 14077-79-3, stock: 8.2g, assay: 96.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₈H₁₂N₂O₃.

Valyltyrosylvaline, CAS: 17355-22-5, stock: 7.9g, assay: 98.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₉H₂₉N₃O₅.

5-[(Hexahydro-2,4,6-trioxo-5-pyrimidinyl)imino]-2,4,6(1H,3H,5H)-pyrimidinetrione Ammonium Salt, CAS: 3051-09-0, stock: 7.3g, assay: 98.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₈H₅N₅O₆ • (NH ₃).

7-Methyluric Acid, CAS: 612-37-3, stock: 6.6g, assay: 96.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₆H₆N₄O₃.

8-13C-Uric Acid (contains ~1.5% unlabelled), CAS: 139290-36-1, stock: 6.9g, assay: 98.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₄¹³CH₄N₄O₃.

9-Methyluric acid, CAS: 55441-71-9, stock: 8.5g, assay: 96.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₆H₆N₄O₃.

Benzyl 3-Oxo-3-ureidopropanoate, CAS: /, stock: 4g, assay: 98.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₁H₁₂N₂O₄.

Bis(1,3-dibutylbarbituric acid) trimethine oxonol, CAS: 70363-83-6, stock: 7g, assay: 96.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₇H₄₀N₄O₆.

Di-p-Methylbenzylidene Sorbitol, CAS: 81541-12-0, stock: 2.2g, assay: 97.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₂H₂₆O₆.

Dibromoisocyanuric Acid, CAS: 15114-43-9, stock: 5.6g, assay: 96.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₃HBr₂N₃O₃.

Dibutyltin Dilaurate, CAS: 77-58-7, stock: 7.8g, assay: 98.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₃₂H₆₄O₄Sn.

Dichloroisocyanuric Acid Sodium Salt, CAS: 2893-78-9, stock: 1.1g, assay: 97%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₃Cl₂N₃NaO₃.

Disodium Tellurite, CAS: 10102-20-2, stock: 4.9g, assay: 97.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  Na₂O₃Te.

Ethyl(1-methylbutyl)malonuric Acid, CAS: 106686-60-6, stock: 8.6g, assay: 98.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₁H₂₀N₂O₄.

Ethylene Glycol Dilaurate, CAS: 624-04-4, stock: 6.5g, assay: 97.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₆H₅₀O₄.

Gentisuric Acid, CAS: 25351-24-0, stock: 7.4g, assay: 97.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₉H₉NO₅.

Idobutal, CAS: 3146-66-5, stock: 1.7g, assay: 96.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₁H₁₆N₂O₃.

Idobutal-d9, CAS: /, stock: 4.7g, assay: 97.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₁H₇D₉N₂O₃.

(2’S)-2’-Deoxy-2’-fluoro-5-ethynyluridine, CAS: 95740-26-4, stock: 4g, assay: 96.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₁H₁₁FN₂O₅.

(E)-5-(2-Carbomethoxyvinyl)-2’-deoxyuridine, CAS: 86163-17-9, stock: 4.9g, assay: 97.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₃H₁₆N₂O₇.

(E)-5-(2-Carbomethoxyvinyl)uridine, CAS: 58931-19-4, stock: 9.7g, assay: 98.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₃H₁₆N₂O₈.

(E)-5-(2-Carboxyvinyl)-2’-deoxyuridine, CAS: 74131-06-9, stock: 5.7g, assay: 97.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₂H₁₄N₂O₇.

(E)-5-(2-Carboxyvinyl)-2’-deoxyuridine N-Hydroxysuccinimide Ester, CAS: 869355-24-8, stock: 7.1g, assay: 96.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₆H₁₇N₃O₉.

(E)-5-(2-Carboxyvinyl)uridine, CAS: 99394-52-2, stock: 5.1g, assay: 98.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₂H₁₄N₂O₈.

1,2,3,5-Tetra-O-acetyl β-D-Ribofuranose, CAS: 13035-61-5, stock: 8.8g, assay: 98.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₃H₁₈O₉.

1,2,3,5-Tetra-O-acetyl β-L-Ribofuranose, CAS: 144490-03-9, stock: 6.8g, assay: 98.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₃H₁₈O₉.

1-C-[2,4-Bis(1,1-dimethylethoxy)-5-pyrimidinyl]-5-O-(1-methoxy-1-methylethyl)-2,3-O-(1-methylethylidene)-α-D-ribofuranose, CAS: 631920-67-7, stock: 7.4g, assay: 96.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₄H₄₀N₂O₈.

Lauric Acid, CAS: 143-07-7, stock: 7.9g, assay: 96.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₂H₂₄O₂.

Lauric Acid Isobutyl Ester, CAS: 37811-72-6, stock: 6.1g, assay: 97.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₆H₃₂O₂.

Lauric Acid N-Amyl Ester, CAS: 08/03/5350, stock: 5.7g, assay: 98.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₇H₃₄O₂.

Lauric Acid-13C12, CAS: /, stock: 4.6g, assay: 97.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  ¹³C₁₂H₂₄O₂.

Lauric Acid-d23, CAS: 59154-43-7, stock: 9.4g, assay: 98.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₂HD₂₃O₂.

1’-Epi 3,5-Dibenzoate-2,2-difluorouridine-13C,15N2, CAS: /, stock: 8.8g, assay: 98.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₂¹³CH₁₈F₂¹⁵N₂O₇.

Lauroyl Chloride, CAS: 112-16-3, stock: 5.4g, assay: 96.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₂H₂₃ClO.

2,2’-Anhydro-3’-O-mesyl-5’-O-benzoyl-5-methyl Uridine, CAS: /, stock: 2g, assay: 98.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₈H₁₈N₂O₈S.

2,2’-Anhydro-L-uridine, CAS: 31501-46-9, stock: 7.6g, assay: 99%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₉H₁₀N₂O₅.

2,2’-O-Anhydro-5-methyluridine, CAS: 22423-26-3, stock: 2.9g, assay: 96.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₀H₁₂N₂O₅.

2,3-Dihydro-2-thioxo-1,3-bis-(2,3,5-tri-O-acetyl-β-D-ribofuranosyl)-4(1H)-pyrimidinone, CAS: /, stock: 5.2g, assay: 98.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₆H₃₂N₂O₁₅S.

2,3-Dihydro-2-thioxo-1-(2,3,5-tri-O-acetyl-α-D-ribofuranosyl)-4(1H)-pyrimidinone, CAS: /, stock: 3.8g, assay: 98.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₅H₁₈N₂O₈S.

2,4-Bis(1,1-dimethylethoxy)pyrimidine-13C,15N2, CAS: /, stock: 2.5g, assay: 96.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₁¹³CH₂₀¹⁵N₂O₂.

2,4-Bis[(trimethylsilyl)oxy]-1,3,5-triazine, CAS: 59957-74-3, stock: 5.5g, assay: 98.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₉H₁₉N₃O₂Si₂.

2,4-Dithiouridine, CAS: 13239-96-8, stock: 4.6g, assay: 98.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₉H₁₂N₂O₄S₂.

2,4-Dithiouridine 2’,3’,5’-Triacetate, CAS: 28542-32-7, stock: 6.7g, assay: 97.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₅H₁₈N₂O₇S₂.

2-Acetylamino-5-bromo-6-methylpyridine, CAS: 142404-84-0, stock: 7.4g, assay: 97.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₈H₉BrN₂O.

2-Azidoethanol, CAS: 1517-05-1, stock: 7.7g, assay: 96.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂H₅N₃O.

2-Fluoro-3-ureidopropenoic Acid, CAS: 76831-42-0, stock: 1.6g, assay: 96.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₄H₅FN₂O₃.

2-Methylthio-N6-isopentenyladenosine, CAS: 20859-00-1, stock: 9g, assay: 96.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₆H₂₃N₅O₄S.

2-Methylthio-N6-isopentenyladenosine-d6, CAS: 1258839-12-1, stock: 9.5g, assay: 96.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₆H₁₇D₆N₅O₄S.

2-Thiouridine 2’,3’,5’-Triacetate, CAS: 28542-31-6, stock: 4.6g, assay: 97.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₅H₁₈N₂O₈S.

2-Thiouridine-5’-O-(α, β-methylene)diphosphate Trisodium Salt, CAS: /, stock: 3.3g, assay: 96%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₀H₁₃N₂Na₃O₁₀P₂S.

2-ThioUTP Tetrasodium Salt, CAS: 1343364-70-4, stock: 2.6g, assay: 96.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₉H₁₁N₂Na₄O₁₄P₃S.

Methyl Laurate, CAS: 111-82-0, stock: 2.6g, assay: 97.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₃H₂₆O₂.

Methyl-d3 Laurate, CAS: 96731-85-0, stock: 9.5g, assay: 97%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₃H₂₃D₃O₂.

2’,3’,5’,5-Tetra-O-t-butyldimethylsilyl-5-methyluridine, CAS: /, stock: 9.4g, assay: 98.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₃₄H₇₀N₂O₇Si₄.

2’,3’,5’-Tri-O-benzoyl-2-thiouridine, CAS: 21052-18-6, stock: 3.7g, assay: 97.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₃₀H₂₄N₂O₈S.

2’,3’,5’-Tri-O-benzoyl-5-fluorouridine-13C,15N2, CAS: /, stock: 5.4g, assay: 97.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₉¹³CH₂₃F¹⁵N₂O₉.

2’,3’,5’-Triacetyluridine, CAS: 4105-38-8, stock: 3.3g, assay: 96.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₅H₁₈N₂O₉.

10-Undecenoic Acid, CAS: 112-38-9, stock: 1.9g, assay: 99%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₁H₂₀O₂.

2’,3’-Di(9-phenylxanthen-9-yl)dithiouridine, CAS: 156592-88-0, stock: 3.3g, assay: 96.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₄₇H₃₆N₂O₆S₂.

2’,3’-Di-O-acetyl-U-5’-CEP, CAS: 208655-84-9, stock: 5.9g, assay: 97.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₂H₃₃N₄O₉P.

10-Undecenoic Acid Methyl-d3 Ester, CAS: 774610-27-4, stock: 3.8g, assay: 96.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₂H₁₉D₃O₂.

10-Undecylenic Aldehyde, CAS: 112-45-8, stock: 9.7g, assay: 97.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₁H₂₀O.

2’,3’-Dideoxy-3’-fluoro-alpha-uridine, CAS: 178374-44-2, stock: 2g, assay: 98.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₉H₁₁FN₂O₄.

Methyl 10-​Undecenoate(10-Undecenoic Acid Methyl Ester), CAS: 111-81-9, stock: 9.5g, assay: 96.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₂H₂₂O₂.

2’,3’-Dideoxy-5-iodouridine, CAS: 105784-83-6, stock: 2.6g, assay: 98%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₉H₁₁IN₂O₄.

N,N-Dimethyl-p-phenylenediamine, CAS: 99-98-9, stock: 8.9g, assay: 97.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₈H₁₂N₂.

2’,3’-Dideoxyuridine, CAS: 05/09/5983, stock: 3.9g, assay: 97.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₉H₁₂N₂O₄.

2’,3’-Dithiouridine, CAS: 156592-92-6, stock: 8.3g, assay: 98.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₉H₁₂N₂O₄S₂.

N,N-Dimethyl-p-phenylenediamine-d6, CAS: 1398066-19-7, stock: 1.4g, assay: 97.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₈H₆D₆N₂.

2’,3’-O-Isopropylidene-5-chlorouridine, CAS: 81356-82-3, stock: 6.9g, assay: 96.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₂H₁₅ClN₂O₆.

2’,3’-O-Isopropylidene-5-fluorouridine, CAS: 2797-17-3, stock: 9.5g, assay: 98.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₂H₁₅FN₂O₆.

2’,3’-O-Isopropylidene-5-fluorouridine-13C,15N2, CAS: /, stock: 5.4g, assay: 98.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₁¹³CH₁₅F¹⁵N₂O₆.

2’,3’-O-Isopropylideneuridine, CAS: 362-43-6, stock: 8.8g, assay: 97.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₂H₁₆N₂O₆.

2’,5’-Dideoxyuridine, CAS: 35959-50-3, stock: 8.7g, assay: 98.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₉H₁₂N₂O₄.

N-Acetyl-d3-S-(3-hydroxypropyl)cysteine, Dicyclohexylammonium Salt, CAS: /, stock: 4.3g, assay: 98.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₀H₃₅D₃N₂O₄S.

2’-Amino-2’-deoxyuridine, CAS: 26889-39-4, stock: 8g, assay: 98.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₉H₁₃N₃O₅.

2’-Bromo-2’-deoxy-D-uridine, CAS: 4753-02-0, stock: 2.2g, assay: 98.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₉H₁₁BrN₂O₅.

2’-Deoxy-2’-fluoro-5-iodouridine, CAS: 183293-80-3, stock: 1.3g, assay: 97.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₉H₁₀FIN₂O₅.

2’-Deoxy-2’-methyleneuridine, CAS: 119410-95-6, stock: 5.6g, assay: 97.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₀H₁₂N₂O₅.

N-Acetyl-S-(3-hydroxypropyl)cysteine Dicyclohexylammonium Salt, CAS: /, stock: 9.5g, assay: 98.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₀H₃₈N₂O₄S.

N-Acetyl-S-(3-hydroxypropyl-1,1,2,2,3,3-D6)cysteine, Dicyclohexylammonium Salt, CAS: /, stock: 7.7g, assay: 98.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₀H₃₂D₆N₂O₄S.

2’-Deoxy-3’,5’-di-O-p-toluoyl Uridine-13C,15N2, CAS: /, stock: 2g, assay: 96.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₄¹³CH₂₄¹⁵N₂O₇.

2’-Deoxy-3’,5’-O-(1,1,3,3-tetraisopropyl-1,3-disiloxanediyl)uridine, CAS: 98495-56-8, stock: 9.5g, assay: 96.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₁H₃₈N₂O₆Si₂.

N-Acetyl-S-(3-hydroxypropyl-1-methyl)-L-cysteine Dicyclohexylammonium Salt(Mixture of Diastereomers), CAS: 33164-70-4, stock: 9.3g, assay: 96.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₁H₄₀N₂O₄S.

N-Acetyl-S-(4-chloro-3-oxobutyl)-L-cysteine, CAS: 1370697-78-1, stock: 6.4g, assay: 96.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₉H₁₄ClNO₄S.

2’-Deoxy-4-thiouridine, CAS: 2165871-22-5, stock: 5.4g, assay: 96.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₉H₁₂N₂O₄S.

2’-Deoxy-5-hydroxyuridine, CAS: 5168-36-5, stock: 5.2g, assay: 98.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₉H₁₂N₂O₆.

2’-Deoxy-5-[2-(trimethylsilyl)ethynyl]-uridine 3’,5’-Bis(4-methylbenzoate), CAS: 77875-91-3, stock: 9.9g, assay: 97.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₃₀H₃₂N₂O₇Si.

2’-Deoxy-5-[3-[(2,2,2-trifluoroacetyl)amino]-1-propyn-1-yl]uridine, CAS: 115899-40-6, stock: 7.1g, assay: 96.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₄H₁₄F₃N₃O₆.

2’-Deoxy-5’-O-DMT-5-iodouridine, CAS: 104375-88-4, stock: 3.7g, assay: 98.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₃₀H₂₉IN₂O₇.

2’-Deoxy-L-uridine-13C,15N2, CAS: /, stock: 3g, assay: 97.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₈¹³CH₁₂¹⁵N₂O₅.

2’-Deoxy-N3-methyluridine, CAS: 24514-32-7, stock: 8.9g, assay: 97.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₀H₁₄N₂O₅.

N-Acetyl-S-phenyl-d5-DL-cysteine, CAS: /, stock: 6.5g, assay: 97.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₁H₈D₅NO₃S.

N-Acetyl-S-phenyl-DL-cysteine-3,3-d2, CAS: /, stock: 8.8g, assay: 98%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₁H₁₁D₂NO₃S.

2’-Deoxyuridine 5’-Monophosphate Disodium Salt, CAS: 42155-08-8, stock: 7.2g, assay: 96.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₉H₁₁N₂Na₂O₈P.

(1-Azabicyclo[2.2.2]oct-4-yl)(diphenyl)methanol, CAS: 461648-39-5, stock: 8.9g, assay: 98.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₀H₂₃NO.

N-Phenylmethyl-7-methyluric Acid, CAS: 72816-95-6, stock: 3.7g, assay: 97.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₃H₁₂N₄O₃.

1-(2-Chloroethyl)-4-piperidinecarboxylic Acid Ethyl Ester, CAS: 869112-14-1, stock: 7.5g, assay: 97.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₀H₁₈ClNO₂.

4-Methyl 4-(1-(tert-Butoxycarbonyl)piperidine-4-carbonyl)piperidine-1,4-dicarboxylic Acid tert-Butyl Ester, CAS: /, stock: 8.9g, assay: 97.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₃H₃₈N₂O₇.

4-Methyl 4-(2-Chloroethyl)piperidine-1,4-dicarboxylic Acid tert-Butyl Ester, CAS: /, stock: 6.2g, assay: 96.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₄H₂₄ClNO₄.

4-Quinuclidinecarboxylic Acid Methyl Ester N-Oxide, CAS: /, stock: 5.8g, assay: 97.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₉H₁₅NO₃.

2’-Deoxyuridine-5’-triphosphate Trisodium Salt, CAS: 102814-08-4, stock: 8.7g, assay: 96.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₉H₁₂N₂O₁₄P₃Na₃.

2’-epi-Fialuridine, CAS: 55612-21-0, stock: 3g, assay: 98.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₉H₁₀FIN₂O₅.

α,α-Diphenyl-1-azabicyclo[2.2.2]octane-4-methanol-d10, CAS: /, stock: 4.7g, assay: 97.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₀H₁₃D₁₀NO.

Umeclidinium Bromide, CAS: 869113-09-7, stock: 4.8g, assay: 98.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₉H₃₄BrNO₂.

2’-Fluoro-2’-deoxyuridine, CAS: 784-71-4, stock: 3.8g, assay: 98.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₉H₁₁FN₂O₅.

Umeclidinium Bromide-d10, CAS: /, stock: 9.2g, assay: 98%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₉H₂₄D₁₀BrNO₂.

Umeclidinium Bromide-d5, CAS: /, stock: 2.7g, assay: 96.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₉H₂₉D₅BrNO₂.

2’-Fluoro-2’-deoxyuridine-2-13C, 1,3-15N2, CAS: /, stock: 1.5g, assay: 97.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₈¹³CH₁₁F¹⁵N₂O₅.

2’-Fluoro-5’-iodo deoxyuridine, CAS: 211694-25-6, stock: 2.9g, assay: 96.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₉H₁₀FIN₂O₄.

2’-Fluoro-5’-iodo Deoxyuridine CEP, CAS: /, stock: 9.5g, assay: 98.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₈H₂₇FIN₄O₅P.

2’-O-(2-Methoxyethyl)-5-methyl-uridine, CAS: 163759-49-7, stock: 2.6g, assay: 96.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₃H₂₀N₂O₇.

2’-O-(2-Methoxyethyl)uridine, CAS: 223777-15-9, stock: 2g, assay: 97.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₂H₁₈N₂O₇.

2’-O-(tert-Butyldimethylsilyl)-3’-deoxy-5’-O-trityluridine, CAS: 130860-12-7, stock: 8.1g, assay: 97.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₃₄H₄₀N₂O₅Si.

2’-O-(tert-Butyldimethylsilyl)-3’-O-(phenoxythioncarbonyl)-5’-O-trityluridine, CAS: 130860-11-6, stock: 6.9g, assay: 96.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₄₁H₄₄N₂O₇SSi.

2’-O-(tert-Butyldimethylsilyl)-5’-O-trityluridine, CAS: 117136-35-3, stock: 9g, assay: 98.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₃₄H₄₀N₂O₆Si.

Perfluorododecanoic Acid, CAS: 307-55-1, stock: 5.8g, assay: 96.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₂HF₂₃O₂.

2’-O-Acetyl-5’-O-benzoyl-5-methyl-3’-deoxyuridine, CAS: 143653-60-5, stock: 8.2g, assay: 98%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₉H₂₀N₂O₇.

2’-O-Methyl Uridine, CAS: 2140-76-3, stock: 9g, assay: 96.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₀H₁₄N₂O₆.

2’-O-Methyluridine 3’,5’-Bis(4-nitrophenyl)phosphate Diester, CAS: /, stock: 5.2g, assay: 96.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₂H₂₂N₄O₁₆P₂.

2α-Hydroxy Zidovudine, CAS: 215176-58-2, stock: 7.8g, assay: 96.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₀H₁₃N₅O₅.

Polyoxyethylene (23) Lauric Acid, CAS: 202408-13-7, stock: 2.9g, assay: 96.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  N/A.

2α-Hydroxy Zidovudine-d3, CAS: /, stock: 4.7g, assay: 96%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₀H₁₀D₃N₅O₅.

3,4,5,6-Tetrahydrouridine (>80%), CAS: 18771-50-1, stock: 9.1g, assay: 98.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₉H₁₆N₂O₆.

3,5-Dibenzoate-2,2-difluorouridine-13C,15N2, CAS: /, stock: 2.8g, assay: 96.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₂¹³CH₁₈F₂¹⁵N₂O₇.

3-Deaza-2’-deoxyuridine-5’-triphosphate, CAS: 1881279-84-0, stock: 6.5g, assay: 96.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₀H₁₆NO₁₄P₃.

3-Deazauridine, CAS: 23205-42-7, stock: 6.2g, assay: 98.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₀H₁₃NO₆.

3-Deazauridine-5’-triphosphate Triethylamine Salt, CAS: /, stock: 1.8g, assay: 96.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₀H₁₆NO₁₅P₃•xC₆H₁₅N.

3-Methyluridine, CAS: 2140-69-4, stock: 9.1g, assay: 97.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₀H₁₄N₂O₆.

3’, 5’-Di-O-acetyl-5-bromo-2’-deoxyuridine, CAS: 6161-23-5, stock: 6.6g, assay: 98%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₃H₁₅BrN₂O₇.

3’,5’-Bis-O-(tert-butyldimethylsilyl)-2’-deoxyuridine, CAS: 64911-18-8, stock: 8.8g, assay: 97.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₁H₄₀N₂O₅Si₂.

S-(2,3,4-Trihydroxybutyl)mercapturic Acid (Mixture of Diatstereomers), CAS: 219965-90-9, stock: 6.1g, assay: 96.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₉H₁₇NO₆S.

S-(2,3,4-Trihydroxybutyl)mercapturic Acid Methyl Ester (Mixture of Diatstereomers), CAS: 1356841-25-2, stock: 2.9g, assay: 96.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₀H₁₉NO₆S.

3’,5’-Bis-O-(tert-butyldimethylsilyl)-5-bromo-2’-deoxyuridine, CAS: 154925-95-8, stock: 8.6g, assay: 96.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₁H₃₉BrN₂O₅Si₂.

3’,5’-Di-O-(p-toluoyl)-5-(2-hydroxyethyl)-2’-deoxyuridine, CAS: 97974-93-1, stock: 1g, assay: 97.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₇H₂₈N₂O₈.

S-(2,4-Dinitrophenyl)mercapturic Acid, CAS: 35897-25-7, stock: 8.1g, assay: 98.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₁H₁₁N₃O₇S.

3’,5’-Di-O-acetyl-2’-deoxy-2’-fluorouridine, CAS: 10212-13-2, stock: 1.4g, assay: 97.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₃H₁₅FN₂O₇.

3’,5’-Di-O-acetyl-2’-deoxy-5-iodouridine, CAS: 1956-30-5, stock: 3.7g, assay: 96.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₃H₁₅IN₂O₇.

S-Phenyl-d5-mercapturic Acid, CAS: /, stock: 9.9g, assay: 97.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₁H₈D₅NO₃S.

3’,5’-Di-O-acetyl-5-fluoro-2’-deoxyuridine, CAS: 110522-47-9, stock: 7.3g, assay: 97.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₃H₁₅FN₂O₇.

3’,5’-Di-O-acetyl-5-fluoro-2’-O-methyluridine, CAS: 869355-34-0, stock: 4.9g, assay: 98.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₄H₁₇FN₂O₈.

3’,5’-Di-O-acetyl-5-fluoro-O4-(2,4,6-trimethylphenyl)-2’-deoxyuridine, CAS: 141120-62-9, stock: 4.1g, assay: 97.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₂H₂₅FN₂O₇.

S-Propyl-2-thiobarbituric Acid, CAS: 145783-12-6, stock: 1.2g, assay: 97.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₇H₁₀N₂O₂S.

3’,5’-Di-O-acetyl-5-fluoro-O4-(2,4,6-trimethylphenyl)-2’-O-methyluridine, CAS: 869355-32-8, stock: 8.8g, assay: 97.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₃H₂₇FN₂O₈.

S-Propyl-5-nitro-2-thiobarbituric-d7 Acid, CAS: 1265919-34-3, stock: 8.5g, assay: 98.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₇H₂D₇N₃O₄S.

3’,5’-Di-O-benzoyl-5-fluoro-2’-O-methyluridine, CAS: 158966-44-0, stock: 8.7g, assay: 97.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₄H₂₁FN₂O₈.

3’-Deoxy Uridine, CAS: 7057-27-4, stock: 7.3g, assay: 98.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₉H₁₂N₂O₅.

3’-Deoxy-5’-O-trityl Uridine, CAS: 161110-05-0, stock: 1.6g, assay: 96.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₈H₂₆N₂O₅.

3’-epi-5-Chloro-2’-deoxyuridine, CAS: 188559-94-6, stock: 2.9g, assay: 98.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₉H₁₁ClN₂O₅.

3’-O-Benzoyl-2’-deoxyuridine, CAS: 53213-02-8, stock: 6.3g, assay: 98.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₆H₁₆N₂O₆.

3’-O-tert-Butyldimethylsilyl-uridine-5’-O-DMT-2’-CE Phosphoramidite, CAS: 129451-77-0, stock: 9.7g, assay: 97.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₄₅H₆₁N₄O₉PSi.

4-(2-Furanyl)-1,2,5,6,7,8-hexahydro-2-thioxo-3-quinolinecarbonitrile, CAS: 83989-90-6, stock: 9.3g, assay: 98.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₄H₁₂N₂OS.

4-Deoxyuridine, CAS: 06/10/3690, stock: 3.4g, assay: 96%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₉H₁₂N₂O₅.

4-Hydroxy-1-(2,3,5-tri-O-benzoyl-β-D-ribofuranosyl)-2(1H)-pyridinone, CAS: 23220-74-8, stock: 7.2g, assay: 96.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₃₁H₂₅NO₉.

4-S-(2-Amino-2-oxoethyl)-4-thiouridine, CAS: /, stock: 5.8g, assay: 97.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₁H₁₅N₃O₆S.

4-Thiouridine, CAS: 13957-31-8, stock: 5.2g, assay: 96.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₉H₁₂N₂O₅S.

4-Thiouridine 2’,3’,5’-Triacetate, CAS: 55003-25-3, stock: 1.3g, assay: 96.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₅H₁₈N₂O₈S.

5,6-Dihydro-2’-deoxyuridine, CAS: 5626-99-3, stock: 4.3g, assay: 96.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₉H₁₄N₂O₅.

Sorbitan Monolaurate, CAS: 1338-39-2, stock: 3.5g, assay: 97.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₈H₃₄O₆.

5,6-Dihydro-5-methyluridine, CAS: 23067-10-9, stock: 8.5g, assay: 97.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₀H₁₆N₂O₆.

5-(1-Propynyl)-2’-deoxyuridine, CAS: 84558-94-1, stock: 5.6g, assay: 98.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₂H₁₄N₂O₅.

5-(1-Propynyl)-2’-O-methyluridine, CAS: 179817-95-9, stock: 4.4g, assay: 96.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₃H₁₆N₂O₆.

5-(2-Fluoroethyl)-2’-deoxyuridine, CAS: 108008-61-3, stock: 6.5g, assay: 98.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₁H₁₅FN₂O₅.

5-(2-Furyl)-dU CEP, CAS: 863713-51-3, stock: 2.9g, assay: 97.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₄₃H₄₉N₄O₉P.

5-(2-Hydroxyethyl)-2’-deoxyuridine, CAS: 90301-60-3, stock: 8.8g, assay: 96.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₁H₁₆N₂O₆.

5-(3-Amino-1-propyn-1-yl)-2’-deoxyuridine 5’-(Tetrahydrogen Triphosphate), CAS: 179101-49-6, stock: 7.5g, assay: 97.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₂H₁₈N₃O₁₄P₃.

5-(3-Aminophenyl)-2’-deoxyuridine, CAS: 188482-60-2, stock: 1.2g, assay: 98.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₅H₁₇N₃O₅.

5-(3-Azidopropyl)-UTP •4TEA, CAS: 1354419-13-8, stock: 4.9g, assay: 98.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₃₆H₈₀N₉O₁₅P₃.

5-(Methoxycarbonylmethyl)-2-thiouridine, CAS: 20299-15-4, stock: 9.9g, assay: 98.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₂H₁₆N₂O₇S.

Tetrachloroauric Acid, CAS: 16903-35-8, stock: 1.5g, assay: 96.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  AuCl₄H.

(E)-5-(2-Bromovinyl)uracil, CAS: 69304-49-0, stock: 3.2g, assay: 96.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₆H₅BrN₂O₂.

(E)-5-(2-Carboxvinyl)uracil, CAS: 57412-59-6, stock: 8.6g, assay: 98.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₇H₆N₂O₄.

5-Amino Uridine Hydrochloride, CAS: 116154-74-6, stock: 2g, assay: 97.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₉H₁₄ClN₃O₆.

5-Aza-(3’,5’-Di-O-p-toluoyl)-2’-deoxyuridine (α Isomer), CAS: /, stock: 6.6g, assay: 97.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₄H₂₃N₃O₇.

5-Aza-(3’,5’-Di-O-p-toluoyl)-2’-deoxyuridine (β Isomer), CAS: 1070994-93-2, stock: 9.8g, assay: 98.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₄H₂₃N₃O₇.

5-Aza-2’-deoxyuridine (α/β mixture), CAS: /, stock: 3.2g, assay: 98.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₈H₁₁N₃O₅.

1,3-Dibutyl-5,6-diaminouracil, CAS: 52998-23-9, stock: 2.6g, assay: 96.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₂H₂₂N₄O₂.

1,3-Diethyl-5,6-diaminouracil, CAS: 52998-22-8, stock: 7g, assay: 99%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₈H₁₄N₄O₂.

5-Aza-2’-deoxyuridine (β Isomer Only), CAS: 25501-08-0, stock: 5.3g, assay: 98.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₈H₁₁N₃O₅.

5-Azauridine, CAS: 1476-82-0, stock: 1.9g, assay: 98.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₈H₁₁N₃O₆.

1,3-Diethyl-5-nitroso-6-aminouracil, CAS: 89073-60-9, stock: 3g, assay: 97.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₈H₁₂N₄O₃.

1,3-Diethyl-6-aminouracil, CAS: 41740-15-2, stock: 7.9g, assay: 99%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₈H₁₃N₃O₂.

5-Azido Uridine, CAS: 1355028-82-8, stock: 9g, assay: 97.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₉H₁₁N₅O₆.

1,3-Dimethyl Barbituric Acid, CAS: 769-42-6, stock: 8.1g, assay: 96.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₆H₈N₂O₃.

1,3-Dimethyluracil, CAS: 874-14-6, stock: 7.2g, assay: 97.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₆H₈N₂O₂.

5-Azidouridine, CAS: 1193451-72-7, stock: 1.9g, assay: 97.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₉H₁₁N₅O₆.

5-​(Acetyl-O-methyl-13C,d2)-​4-​O-​methyl-​uridine 2’,​3’,​5’-​Tribenzoate, CAS: /, stock: 4.8g, assay: 97.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₃₃¹³CH₂₈D₂N₂O₁₁.

1,3-Dimethyluracil-5-boronic acid pinacol ester, CAS: 269410-01-7, stock: 4.8g, assay: 96.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₂H₁₉BN₂O₄.

1,4-Anhydro-5-O-[bis(4-methoxyphenyl)phenylmethyl]-2-deoxy-D-erythro-pentitol, CAS: 95049-01-7, stock: 8.1g, assay: 97.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₆H₂₈O₅.

5-​(Bromomethyl-13C,d2)-​4-​O-​methyl-​uridine 2’,​3’,​5’-​Tribenzoate, CAS: /, stock: 1.2g, assay: 98.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₃₁¹³CH₂₅D₂BrN₂O₉.

5-​(Methyl-13C,d3)-​4-​O-​methyl-​uridine 2’,​3’,​5’-​Tribenzoate, CAS: /, stock: 2.3g, assay: 98.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₃₁¹³CH₂₅D₃N₂O₉.

1,6-Dimethyl-1H-pyrimidine-2,4-dione, CAS: 1627-27-6, stock: 6.5g, assay: 96.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₆H₈N₂O₂.

1-(2-Deoxy-2-fluoro-b-D-arabinofuranosyl)uracil, CAS: 69123-94-0, stock: 1.8g, assay: 98%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₉H₁₁FN₂O₅.

5-​[2-​[[6-​[[(2R)​-​2-​Amino-​3-​mercapto-​1-​oxopropyl]​amino]​hexyl]​amino]​-​2-​oxoethyl]​-​2’-​deoxy-uridine 5’-​(tetrahydrogen triphosphate)​, CAS: 885109-31-9, stock: 7.8g, assay: 96.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₀H₃₆N₅O₁₆P₃S.

5-​[3-​[(Aminoiminomethyl)​amino]​-​1-​propynyl]​-​2’-​deoxy-uridine 5’-​(tetrahydrogen triphosphate)​, CAS: 402932-20-1, stock: 6.5g, assay: 97.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₃H₂₀N₅O₁₄P₃.

Trichloroisocyanuric Acid, CAS: 87-90-1, stock: 2.8g, assay: 97.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₃Cl₃N₃O₃.

1-(2’-Deoxy-2’-fluoro-beta-d-arabinofuranosyl)-5-ethyluracil, CAS: 1417190-75-0, stock: 1.4g, assay: 96.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₁H₁₅FN₂O₅.

5-Bromo-2,4-bis(1,1-dimethylethoxy)pyrimidine, CAS: 19752-61-5, stock: 3g, assay: 98.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₂H₁₉BrN₂O₂.

5-Bromo-2,4-bis(1,1-dimethylethoxy)pyrimidine-13C,15N2, CAS: /, stock: 6.6g, assay: 98.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₁¹³CH₁₉Br¹⁵N₂O₂.

1-(3-tert-Butyl-5-iodo-4-methoxyphenyl)pyrimidine-2,4(1H,3H)-dione, CAS: 1132940-53-4, stock: 1.8g, assay: 97.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₅H₁₇IN₂O₃.

1-D-Arabinofuranosyluracil-13C,15N2 2’,3’,5’-Tribenzoate (α,β Mixture), CAS: /, stock: 3.5g, assay: 97.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₃₀H₂₄N₂O₉.

5-Bromo-2’,3’,5’-tri-O-acetyluridine, CAS: 105659-32-3, stock: 1.4g, assay: 96.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₅H₁₇BrN₂O₉.

Tris(3,5-di-tert-butyl-4-hydroxybenzyl) Isocyanurate, CAS: 27676-62-6, stock: 9.8g, assay: 98.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₄₈H₆₉N₃O₆.

1-Ethyl-6-aminouracil, CAS: 41862-09-3, stock: 8.2g, assay: 96.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₆H₉N₃O₂.

5-Bromo-2’-deoxy-2’-fluorouridine, CAS: 55612-18-5, stock: 6.4g, assay: 98.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₉H₁₀BrFN₂O₅.

Tris(4-tert-butyl-3-hydroxy-2,6-dimethylbenzyl) Isocyanurate, CAS: 40601-76-1, stock: 9.8g, assay: 96.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₄₂H₅₇N₃O₆.

Trithiocyanuric Acid, CAS: 638-16-4, stock: 1.2g, assay: 98.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₃H₃N₃S₃.

1-β-D-Arabinofuranosyluracil, CAS: 3083-77-0, stock: 9.8g, assay: 96.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₉H₁₂N₂O₆.

1-β-D-Arabinofuranosyluracil 5’-Monophosphate, CAS: 18354-06-8, stock: 4.1g, assay: 96.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₉H₁₃N₂O₉P.

5-Bromo-2’-deoxyuridine-5’-monophosphate Sodium Salt, CAS: 51432-32-7, stock: 2.2g, assay: 96.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₉H₁₂BrN₂O₈PNa₂.

Uric Acid, CAS: 69-93-2, stock: 4.3g, assay: 97.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₅H₄N₄O₃.

Uric Acid-1,3-15N2, CAS: 62948-75-8, stock: 9.6g, assay: 96.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₅H₄N₂¹⁵N₂O₃.

1-β-D-Arabinofuranosyluracil-13C,15N2, CAS: /, stock: 9.4g, assay: 98.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₈¹³CH₁₂¹⁵N₂O₆.

1-β-D-Arabinofuranosyluracil-13C,15N2 5’-Monophosphate, CAS: /, stock: 9.4g, assay: 97.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₈¹³CH₁₃¹⁵N₂O₉P.

5-Bromo-2’-O-methyluridine, CAS: 34218-83-2, stock: 4g, assay: 96.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₀H₁₃BrN₂O₆.

5-Bromouridine, CAS: 957-75-5, stock: 6.9g, assay: 98.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₉H₁₁BrN₂O₆.

Uric Acid-13C,15N2, CAS: /, stock: 8.8g, assay: 98%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₄¹³CH₄N₂¹⁵N₂O₃.

Uric Acid-13C3, CAS: /, stock: 1.5g, assay: 97.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂¹³C₃H₄N₄O₃.

5-Chloro-2’-deoxyuridine, CAS: 50-90-8, stock: 3.6g, assay: 97.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₉H₁₁ClN₂O₅.

Uric Acid-d2, CAS: /, stock: 1.3g, assay: 97.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₅H₂D₂N₄O₃.

1-Methyluracil, CAS: 615-77-0, stock: 7.8g, assay: 98.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₅H₆N₂O₂.

5-Chloro-3’,5’-di-O-acetyl-2’-deoxyuridine, CAS: 6046-63-5, stock: 2.2g, assay: 97.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₃H₁₅ClN₂O₇.

(17α)-3,3-[1,2-Ethanediylbis(oxy)]-17-hydroxyestra-5(10),9(11)-diene-17-carbonitrile, CAS: 33300-19-5, stock: 1.1g, assay: 96.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₁H₂₇NO₃.

Violuric Acid, CAS: 87-39-8, stock: 2.7g, assay: 97.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₄H₃N₃O₄.

1H-Thieno[3,4-d]pyrimidine-2,4-dione, CAS: 6251-30-5, stock: 8.7g, assay: 96.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₆H₄N₂O₂S.

5-Chloro-5’-deoxyuridine, CAS: /, stock: 6.5g, assay: 98.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₉H₁₁ClN₂O₅.

5-Chlorouridine, CAS: 2880-89-9, stock: 4.6g, assay: 98.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₉H₁₁ClN₂O₆.

N,N-Didesmethyl Ulipristal, CAS: /, stock: 9.4g, assay: 96.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₆H₃₁NO₃.

N-Desmethyl Ulipristal, CAS: 159681-67-1, stock: 9.2g, assay: 97.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₇H₃₃NO₃.

2,3,4,5-Tetrahydro-3,5-dioxo-1,2,4-triazine-6-carboxaldehyde, CAS: 97776-60-8, stock: 8.5g, assay: 97.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₄H₃N₃O₃.

N-Desmethyl Ulipristal Acetate, CAS: 159681-66-0, stock: 2.7g, assay: 98%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₉H₃₅NO₄.

N-Desmethyl Ulipristal Acetate-d3, CAS: /, stock: 7.1g, assay: 96.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₉H₃₂D₃NO₄.

5-Ethynyl Uridine CEP, CAS: 1193451-06-7, stock: 2.7g, assay: 97.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₄₇H₆₁N₄O₉PSi.

5-Ethynyl-2’-deoxyuridine, CAS: 61135-33-9, stock: 3.3g, assay: 96.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₁H₁₂N₂O₅.

2-Iodopropane (Stabilized with Copper), CAS: 75-30-9, stock: 6.4g, assay: 98.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₃H₇I.

Ulipristal, CAS: 159811-51-5, stock: 4.2g, assay: 98.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₈H₃₅NO₃.

Ulipristal Acetate, CAS: 126784-99-4, stock: 9.8g, assay: 97.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₃₀H₃₇NO₄.

2,4-Dihydroxy-6-methyl-5-nitropyrimidine, CAS: 16632-21-6, stock: 5.6g, assay: 96.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₅H₅N₃O₄.

2,4-Dihydroxypyridine, CAS: 626-03-9, stock: 5.5g, assay: 96.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₅H₅NO₂.

5-Ethynyl-2’-deoxyuridine-d1, CAS: /, stock: 8.7g, assay: 98%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₁H₁₁DN₂O₅.

5-Ethynyluridine, CAS: 69075-42-9, stock: 7.9g, assay: 96.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₁H₁₂N₂O₆.

2-Iodopropane-d7, CAS: 101927-33-7, stock: 8.7g, assay: 98.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₃D₇I.

Ulipristal Acetate-d3, CAS: 1621894-62-9, stock: 2.9g, assay: 98.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₃₀H₃₄D₃NO₄.

Ulipristal Acetate-d3, CAS: /, stock: 3.6g, assay: 96.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₃₀H₃₄D₃NO₄.

2,4-Dimethoxypyrimidine, CAS: 3551-55-1, stock: 6.5g, assay: 96.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₆H₈N₂O₂.

5-Fluoro Uridine, CAS: 316-46-1, stock: 8.4g, assay: 98.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₉H₁₁FN₂O₆.

5-Fluoro-2’-deoxyuridine 5’-Monophosphate Ammonium Salt(up to 20% 3’-monophosphate), CAS: /, stock: 8.8g, assay: 97%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₉H₁₂FN₂O₈P  •xNH₃.

Ulipristal-d3, CAS: 159811-51-5, stock: 2g, assay: 98.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₈H₃₂D₃NO₃.

2,​4(1H,​3H)​-​Pyrimidinedione-​2-​13C, CAS: 35803-45-3, stock: 5.6g, assay: 97.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₃¹³CH₄N₂O₂.

5-Fluoro-2’-O-methyl-4-(methylithio)uridine, CAS: 869222-67-3, stock: 4.8g, assay: 97.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₁H₁₅FN₂O₅S.

5-Fluoro-2’-O-methyl-4-thiouridine, CAS: 869355-51-1, stock: 8.5g, assay: 96.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₀H₁₃FN₂O₅S.

5-Fluoro-2’-O-methyluridine, CAS: 61671-80-5, stock: 5.8g, assay: 98.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₀H₁₃FN₂O₆.

5-Fluoro-O4-(2,4,6-trimethylphenyl)-2’-O-methyluridine, CAS: 444788-89-0, stock: 5.3g, assay: 97.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₉H₂₃FN₂O₆.

4-Methylumbelliferyl Decanoate, CAS: 66185-70-4, stock: 3.2g, assay: 98.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₀H₂₆O₄.

2-Methylthio Uracil, CAS: 5751-20-2, stock: 3.7g, assay: 96.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₅H₆N₂OS.

2-Thio 2’-Deoxyuridine, CAS: 35059-12-2, stock: 6g, assay: 98.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₉H₁₂N₂O₄S.

4-Methylumbelliferyl α-D-Galactopyranoside, CAS: 38597-12-5, stock: 8.2g, assay: 96.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₆H₁₈O₈.

4-Methylumbelliferyl β-D-Fucoside, CAS: 55487-93-9, stock: 1.4g, assay: 96.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₆H₁₈O₇.

2-Thiouracil, CAS: 141-90-2, stock: 3.8g, assay: 98.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₄H₄N₂OS.

2-Thiouridine, CAS: 20235-78-3, stock: 8g, assay: 97.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₉H₁₂N₂O₅S.

5-Fluorouridine-13C,15N2, CAS: /, stock: 6.3g, assay: 97.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₈¹³CH₁₁F¹⁵N₂O₆.

4-Methylumbelliferyl β-D-Glucuronide, CAS: 6160-80-1, stock: 2.5g, assay: 97.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₆H₁₆O₉.

4-Methylumbelliferyl β-D-glucuronide Dihydrate, CAS: /, stock: 3.4g, assay: 97.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₆H₁₆O₉ • 2H ₂O.

2’,3’-Didehydro-2’,3’-dideoxyuridine, CAS: 5974-93-6, stock: 9.7g, assay: 98%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₉H₁₀N₂O₄.

2’,3’-Dideoxy-3’-fluorouridine, CAS: 41107-56-6, stock: 7.7g, assay: 96.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₉H₁₁FN₂O₄.

5-Hydroxyuridine, CAS: 957-77-7, stock: 8.8g, assay: 98.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₉H₁₂N₂O₇.

2’-C-Methyluridine, CAS: 31448-54-1, stock: 7.2g, assay: 97.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₀H₁₄N₂O₆.

2’-Deoxy L-Uridine-13C,15N2, CAS: /, stock: 5.8g, assay: 97%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₈¹³CH₁₂¹⁵N₂O₅.

5-Iodo-2’-deoxyuridine Triphosphate Tetralithium Salt, CAS: 3731-55-3, stock: 9.6g, assay: 97.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₉H₁₀ILi₄N₂O₁₄P₃.

5-Iodo-2’-O-methyluridine, CAS: 34218-84-3, stock: 6.6g, assay: 99%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₀H₁₃IN₂O₆.

2’-Deoxy-2-O-ethyluridine, CAS: 66656-47-1, stock: 2.5g, assay: 98.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₁H₁₆N₂O₅.

2’-Deoxycytidine-5-carboxylic Acid Sodium Salt (>85%), CAS: /, stock: 8.1g, assay: 98.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₀H₁₂N₃NaO₆.

5-Iodo-dU CEP, CAS: 178925-48-9, stock: 2.1g, assay: 98.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₃₉H₄₆IN₄O₈P.

2’-Deoxyuridine, CAS: 951-78-0, stock: 9.6g, assay: 96.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₉H₁₂N₂O₅.

5-Isopropyl-2’-deoxyuridine, CAS: 60136-25-6, stock: 9.2g, assay: 98.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₂H₁₈N₂O₅.

2’-Deoxyuridine-13C,15N2, CAS: 369656-76-8, stock: 2.8g, assay: 97.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₈¹³CH₁₂¹⁵N₂O₅.

2’-Deoxyuridine-1’,2’,3’,4’,5’-13C5, CAS: 478510-94-0, stock: 7.9g, assay: 98.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₄¹³C₅H₁₂N₂O₅.

5-Methoxycarbonyl Methyl Uridine, CAS: 29428-50-0, stock: 5.7g, assay: 96%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₂H₁₆N₂O₈.

2’-Deoxyuridine-1’-13C, CAS: 478510-85-9, stock: 9.5g, assay: 98.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₈¹³CH₁₂N₂O₅.

2’-Deoxyuridine-1’-d, CAS: 951-78-0, stock: 9.7g, assay: 97.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₉H₁₁DN₂O₅.

5-Methoxyuridine, CAS: 35542-01-9, stock: 5.7g, assay: 96.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₀H₁₄N₂O₇.

2’-Deoxyuridine-2’-13C, CAS: 478510-87-1, stock: 4g, assay: 98.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₈¹³CH₁₂N₂O₅.

2’-Deoxyuridine-3’-13C, CAS: 478510-89-3, stock: 2.9g, assay: 96.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₈¹³CH₁₁N₂O₅.

5-Methyl-3’-deoxyuridine, CAS: 7084-29-9, stock: 9.7g, assay: 96.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₀H₁₄N₂O₅.

2’-Deoxyuridine-5’,5’’-d2, CAS: 478511-30-7, stock: 3.2g, assay: 96.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₉H₁₀D₂N₂O₅.

2’-Deoxyuridine-5’-13C, CAS: 478510-91-7, stock: 4.7g, assay: 97.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₈¹³CH₁₁N₂O₅.

2’-Fluoro-5-methyl-1-β-D-arabinofuranosyluracil, CAS: 69256-17-3, stock: 9.5g, assay: 98.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₀H₁₃FN₂O₅.

5-O-(1-Methoxy-1-methylethyl)-2,3-O-(1-methylethylidene)-D-ribonic Acid γ-Lactone, CAS: 162635-53-2, stock: 7.3g, assay: 97.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₂H₂₀O₆.

5-Uridineacetic Acid, CAS: 20964-06-1, stock: 1.5g, assay: 98.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₁H₁₄N₂O₈.

3-(2,4-Dioxo-3,4-dihydro-2H-pyrimidin-1-yl)propionic Acid, CAS: 2950-82-5, stock: 2.1g, assay: 96.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₇H₈N₂O₄.

5-[2-[(6-Aminohexyl)amino]-2-oxoethyl]-2’-deoxyuridine 5’-(Tetrahydrogen Triphosphate), CAS: 402789-71-3, stock: 7.8g, assay: 96.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₇H₃₁N₄O₁₅P₃.

5-[2-[[6-[[(2S)-2-Amino-5-[(aminoiminomethyl)amino]-1-oxopentyl]amino]hexyl]amino]-2-oxoethyl]-2’-deoxyuridine 5’-(tetrahydrogen triphosphate), CAS: 885109-28-4, stock: 2.1g, assay: 96.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₃H₄₃N₈O₁₆P₃.

3-Allyl-6-amino-1-ethyluracil, CAS: 63981-29-3, stock: 1.6g, assay: 97.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₉H₁₃N₃O₂.

3-sec-Butyl-6-methyluracil, CAS: 6589-36-2, stock: 3.9g, assay: 96.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₉H₁₄N₂O₂.

5-[N-(2-Aminoethyl)-3-(E)-acrylamido]-5’-O-(dimethoxytrityl)-2’-deoxyuridine, CAS: 606126-32-3, stock: 7.2g, assay: 96%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₃₅H₃₈N₄O₈.

5-[N-(6-(Trifluoracetamido)hexyl)-(E)-acrylamido]uridine, CAS: 869222-70-8, stock: 5.5g, assay: 97.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₀H₂₇F₃N₄O₈.

3’,5’-Di-O-acetyl-2’-deoxyuridine, CAS: 13030-62-1, stock: 8.3g, assay: 97%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₃H₁₆N₂O₇.

5’-Azido-2’,5’-dideoxyuridine, CAS: 35959-37-6, stock: 7.6g, assay: 97.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₉H₁₁N₅O₄.

5’-Chloro-5’-deoxyuridine, CAS: 19556-54-8, stock: 3.3g, assay: 98.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₉H₁₁ClN₂O₅.

3’,5’-Di-O-benzoyl Fialuridine, CAS: 97614-45-4, stock: 1.9g, assay: 96.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₃H₁₈FIN₂O₇.

3’,5’-Di-O-benzoyl Fialuridine (1:3 α/β Mixture), CAS: /, stock: 9.8g, assay: 96.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₃H₁₈FIN₂O₇.

5’-Deoxy-2’,3’-O-isopropylidene-5-fluorouridine, CAS: 66335-39-5, stock: 7.2g, assay: 98.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₂H₁₅FN₂O₅.

5’-Deoxy-2’,3’-O-isopropylidene-5-fluorouridine-13C,15N2, CAS: /, stock: 6g, assay: 96.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₁¹³CH₁₅F¹⁵N₂O₅.

3’-Azido-2’,3’-dideoxyuridine, CAS: 84472-85-5, stock: 7.3g, assay: 96.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₉H₁₁N₅O₄.

5’-Deoxy-5’-iodo-2’,3’-O-isopropylidene-5-chlorouridine, CAS: 94048-47-2, stock: 1.6g, assay: 98%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₂H₁₄ClIN₂O₅.

4,5-Diamino-3-isobutyl-1-methylpyrimidine-2,6-dione, CAS: 78033-18-8, stock: 2.3g, assay: 98.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₉H₁₆N₄O₂.

5’-Deoxy-5’-iodo-2’,3’-O-isopropylidene-5-fluorouridine, CAS: 61787-10-8, stock: 7.1g, assay: 97.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₂H₁₄FIN₂O₅.

5’-Deoxy-5’-iodo-2’,3’-O-isopropylidene-5-fluorouridine-13C,15N2  >95%, CAS: /, stock: 2.6g, assay: 97.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₁¹³CH₁₄FI¹⁵N₂O₅.

4,5-Diamino-6-hydroxy-2-mercaptopyrimidine, CAS: 1004-76-8, stock: 5.5g, assay: 96.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₄H₆N₄OS.

4,5-Diaminopyrimidine, CAS: 13754-19-3, stock: 8.7g, assay: 98.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₄H₆N₄.

5’-Deoxy-5’-iodo-5-fluorouridine-13C,15N2 ,  >95%, CAS: /, stock: 7.6g, assay: 98.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₈¹³CH₁₀FI¹⁵N₂O₅.

4,6-Dichloro-2-hydroxypyrimidine, CAS: 6297-80-9, stock: 6.2g, assay: 97.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₄H₂Cl₂N₂O.

4-Amino-2,6-dihydroxy-5-nitrosopyrimidine Sodium Salt, CAS: 2209-71-4, stock: 3g, assay: 96.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₄H₃N₄NaO₃.

5’-Deoxyuridine, CAS: 15958-99-3, stock: 9.9g, assay: 98%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₉H₁₂N₂O₅.

5’-O-(4,4’-Dimethoxytrityl)-2’-deoxyuridine, CAS: 23669-79-6, stock: 5.5g, assay: 98.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₃₀H₃₀N₂O₇.

4-Amino-3-isobutyl-1-methylpyrimidine-2,6-dione, CAS: 58481-39-3, stock: 5.3g, assay: 98.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₉H₁₅N₃O₂.

4-Amino-3-isobutylpyrimidine-2,6-dione, CAS: 56075-75-3, stock: 2.4g, assay: 98.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₈H₁₃N₃O₂.

5’-O-(4,4’-Dimethoxytrityl)-5-bromo-2’-deoxyuridine, CAS: 63660-21-9, stock: 2.5g, assay: 98.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₃₀H₂₉BrN₂O₇.

5’-O-(4,4’-Dimethyltrityl)uridine, CAS: 81246-79-9, stock: 9.5g, assay: 97.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₃₀H₃₀N₂O₈.

5’-O-(Dimethoxytrityl)-2’-O-methyluridine, CAS: 103285-22-9, stock: 9.2g, assay: 98.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₃₁H₃₂N₂O₈.

5’-O-(Dimethoxytrityl)-5-(1-propynyl)-2’-deoxyuridine, CAS: 644962-74-3, stock: 1.5g, assay: 97.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₃₃H₃₂N₂O₇.

4-​Bromo-​2,​6-​diaminopyridine, CAS: 329974-09-6, stock: 3.7g, assay: 96.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₅H₆BrN₃.

4-Benzyloxypyridine N-Oxide, CAS: 2683-66-1, stock: 7.3g, assay: 99%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₂H₁₁NO₂.

5’-O-(Dimethoxytrityl)-5-(1-propynyl)-2’-O-methyluridine, CAS: 644962-77-6, stock: 4.3g, assay: 98.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₃₄H₃₄N₂O₈.

4-Hydroxy-1-methyl-2-pyridone, CAS: 40357-87-7, stock: 3.8g, assay: 97.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₆H₇NO₂.

4-Hydroxy-1-methyl-d3-2-pyridone, CAS: /, stock: 4.5g, assay: 96.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₆H₄D₃NO₂.

5’-O-(Dimethoxytrityl)-5-iodo-2’-O-methyluridine, CAS: 588691-24-1, stock: 8.2g, assay: 96.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₃₁H₃₁IN₂O₈.

4-Pentylphenylacetylene, CAS: 79887-10-8, stock: 5.5g, assay: 97.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₃H₁₆.

4-Pentylphenylacetylene-d7, CAS: /, stock: 9.1g, assay: 97.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₃H₉D₇.

5’-O-(Dimethoxytrityl)-5-methyl-3’-deoxyuridine, CAS: 114551-15-4, stock: 3.7g, assay: 98%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₃₁H₃₂N₂O₇.

5’-O-(Dimethoxytrityl)-5-[N-(2-(trifluoroacetamido)ethyl)-3-(E)acrylamido]-2’-deoxyuridine, CAS: 153512-23-3, stock: 3.2g, assay: 96.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₃₇H₃₇F₃N₄O₉.

4-Thiouracil, CAS: 591-28-6, stock: 8g, assay: 96.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₄H₄N₂OS.

5’-O-(Dimethoxytrityl)-5-[N-(6-(trifluoroacetamido)hexyl)-3-(E)-acrylamido]-2’-deoxyuridine, CAS: 252337-59-0, stock: 9g, assay: 97.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₄₁H₄₅F₃N₄O₉.

5,6-Diamino-1,3-dimethyl Uracil, CAS: 5440-00-6, stock: 2.3g, assay: 97.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₆H₁₀N₄O₂.

5,6-Diamino-1,3-dipropyluracil, CAS: 81250-34-2, stock: 3.4g, assay: 98.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₀H₁₈N₄O₂.

5’-O-DMT-2’-O-(2-methoxyethyl)-5-methyluridine, CAS: 163759-50-0, stock: 1.1g, assay: 98.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₃₄H₃₈N₂O₉.

5’-O-DMT-2’-O-methyl-5-methyluridine, CAS: 153631-19-7, stock: 8.4g, assay: 96.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₃₂H₃₄N₂O₈.

5,6-Diamino-2,4-dihydroxypyrimidine, Hydrochloride Salt, CAS: 53608-89-2, stock: 9.8g, assay: 97.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₄H₇ClN₄O₂.

5,6-Diamino-2,4-dihydroxypyrimidine-13C2 Bisulfite Salt, CAS: /, stock: 3g, assay: 98.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂¹³C₂H₈N₄O₅S.

5’-O-DMT-2’-O-methyluridine 3’-CE Phosphoramidite, CAS: 110764-79-9, stock: 6.9g, assay: 96.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₄₀H₄₉N₄O₉P.

5’-O-DMT-2’-TBDMS-Uridine, CAS: 81246-80-2, stock: 6.1g, assay: 98.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₃₆H₄₄N₂O₈Si.

5,6-Diamino-2,4-dihydroxypyrimidine-13C2, Hydrochloride Salt, CAS: 1346605-20-6, stock: 4.1g, assay: 98.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂¹³C₂H₇ClN₄O₂.

5,6-Diamino-2-thiouracil Hydrochloride Salt (80%), CAS: /, stock: 7.6g, assay: 98.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₄H₆N₄OS (xHCl).

5’-O-Trityl Uridine, CAS: 05/10/6554, stock: 3.9g, assay: 97.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₈H₂₆N₂O₆.

5’-O-Trityluridine-2’,3’-lyxo-epoxide, CAS: 96253-10-0, stock: 2.5g, assay: 98%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₈H₂₄N₂O₅.

5,6-Diamino-2-thiouracil-13C,15N, CAS: 1246816-80-7, stock: 2g, assay: 98.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₃¹³CH₆N₃¹⁵NOS.

5,6-Diamino-3-methyluracil, Hemihydrate, CAS: /, stock: 5g, assay: 98.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₅H₈N₄O₂•1/2H₂O.

6-Aza-2-thiouridine, CAS: 27089-56-1, stock: 1.9g, assay: 98.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₈H₁₁N₃O₅S.

5,6-Diamino-3-methyluracil-d3, CAS: 1246816-74-9, stock: 6.2g, assay: 97.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₅H₅D₃N₄O₂.

6-Azauridine Triacetate, CAS: 2169-64-4, stock: 2.6g, assay: 96.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₄H₁₇N₃O₉.

5,6-Diaminouracil, CAS: 32014-70-3, stock: 8.6g, assay: 98.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₄H₆N₄O₂.

6-Azauridine-5’-monophosphate, CAS: 2018-19-1, stock: 2.6g, assay: 98%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₈H₁₂N₃O₉P.

5,6-Diaminouracil Sulfate, CAS: 42965-55-9, stock: 2.8g, assay: 98.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₄H₈N₄O₆S.

5,6-Dihydro Thymine, CAS: 696-04-8, stock: 5.5g, assay: 97.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₅H₈N₂O₂.

6-Methyluridine, CAS: 16710-13-7, stock: 6.7g, assay: 98.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₀H₁₄N₂O₆.

5,6-Dihydro Thymine-d6, CAS: 334473-42-6, stock: 9.8g, assay: 97%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₅H₂D₆N₂O₂.

5,6-Dihydro Uracil-13C,15N2, CAS: 181516-96-1, stock: 7.8g, assay: 97.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₃¹³CH₆¹⁵N₂O₂.

5,6-Dihydro-6-methyluracil, CAS: 2434-49-3, stock: 2.9g, assay: 97.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₅H₈N₂O₂.

5,6-Dihydrouridine, CAS: 04/05/5627, stock: 7.8g, assay: 96.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₉H₁₄N₂O₆.

5,6-Dimethylthiouracil, CAS: 28456-54-4, stock: 8g, assay: 96.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₆H₈N₂OS.

5-(1-Cyclohexen-1-yl)-5-ethyl-6-imino-hydrouracil, CAS: 6297-72-9, stock: 4.9g, assay: 96.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₂H₁₇N₃O₂.

5-(3-Keto-cyclohexyl)uracil, CAS: /, stock: 7.1g, assay: 97.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₀H₁₂N₂O₃.

5-(Difluoromethyl)-2,4(1H,3H)-pyrimidinedione, CAS: 670-19-9, stock: 2.3g, assay: 97.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₅H₄F₂N₂O₂.

4,5-Dimethyl-1,3-dioxol-2-one, CAS: 37830-90-3, stock: 6g, assay: 97.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₅H₆O₃.

Adenylyl-(3’->5’)uridine 3’-Monophosphate, CAS: /, stock: 2.8g, assay: 97.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₉H₂₅N₇O₁₅P₂.

Prulifloxacin, CAS: 123447-62-1, stock: 6.4g, assay: 96.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₁H₂₀FN₃O₆S.

Prulifloxacin-d8, CAS: 1246819-37-3, stock: 2.7g, assay: 96.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₁H₁₂D₈FN₃O₆S.

Ulifloxacin, CAS: 112984-60-8, stock: 1.6g, assay: 98.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₆H₁₆FN₃O₃S.

Ulifloxacin Acyl-β-D-glucuronide, CAS: 172040-93-6, stock: 2.5g, assay: 96.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₂H₂₄FN₃O₉S.

Ulifloxacin-d8, CAS: 1246820-95-0, stock: 8.3g, assay: 97.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₆H₈D₈FN₃O₃S.

Brivudine, CAS: 69304-47-8, stock: 3g, assay: 98.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₁H₁₃BrN₂O₅.

5-Allyl-5-(pent-2-yl)-4-imino-2-thiobarbituric Acid, CAS: 737706-07-9, stock: 2.8g, assay: 96.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₂H₁₉N₃OS.

Brivudine 5’-Monophosphate, CAS: 80860-82-8, stock: 1.4g, assay: 98.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₁H₁₄BrN₂O₈P.

Brivudine-13C4,15NH2, CAS: /, stock: 1.4g, assay: 98%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₇¹³C₄H₁₃Br¹⁵N₂O₅.

5-Allyl-6-imino-5-(1-methyl-2-pentynyl)hydrouracil, CAS: 100705-86-0, stock: 9.6g, assay: 97.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₃H₁₇N₃O₂.

5-Allyl-6-imino-5-(1-methyl-2-pentynyl)hydrouracil-13C,15N2, CAS: /, stock: 8.3g, assay: 97.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₂¹³CH₁₇N¹⁵N₂O₂.

5-Amino-4-D-ribitylaminouracil Dihydrochloride (90%), CAS: /, stock: 5.8g, assay: 97.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₉H₁₆N₄O₆  •2HCl.

5-Amino-4-D-ribitylaminouracil Dihydrochloride-13C3 (90%), CAS: /, stock: 5g, assay: 97.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₆¹³C₃H₁₆N₄O₆ • 2HCl.

5-Amino-6-(D-ribitylamino)uracil, CAS: 17014-74-3, stock: 7.1g, assay: 96.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₉H₁₆N₄O₆.

5-Amino-6-methylpyrimidine-2,4-diol, CAS: 6270-46-8, stock: 4.6g, assay: 98.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₅H₇N₃O₂.

5-Aminouracil, CAS: 932-52-5, stock: 5.8g, assay: 97.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₄H₅N₃O₂.

5-Azauracil, CAS: 71-33-0, stock: 8.4g, assay: 97.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₃H₃N₃O₂.

5-Bromo-2,4-pyrimidinedione-13C,15N2, CAS: 181517-13-5, stock: 1.2g, assay: 97.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₄H₃BrN₂O₂.

5-Bromo-6-azauracil, CAS: 02/05/4956, stock: 6g, assay: 96%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₃H₂BrN₃O₂.

5-Bromodihydrouracil, CAS: 1193-76-6, stock: 4.1g, assay: 98.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₄H₅BrN₂O₂.

5-Bromodihydrouracil-13C1, 15N2, CAS: /, stock: 7.5g, assay: 98.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₃¹³CH₅Br¹⁵N₂O₂.

5-Bromomethyl-2-chloropyridine, CAS: 182924-36-3, stock: 3.1g, assay: 98.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₆H₅BrClN.

5-Bromouracil, CAS: 51-20-7, stock: 4.5g, assay: 97.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₄H₃BrN₂O₂.

Diquafosol Sodium Salt (90%), CAS: /, stock: 7.9g, assay: 96.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₈H₂₆N₄O₂₃P₄ .(xNa).

5-Carbethoxyuracil, CAS: 28485-17-8, stock: 6.4g, assay: 97.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₇H₈N₂O₄.

5-Carboxy-2-thiouracil, CAS: 23945-50-8, stock: 4.7g, assay: 98%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₅H₄N₂O₃S.

DMT-2′O-TBDMS-rU Phosphoramidite, CAS: 118362-03-1, stock: 2.3g, assay: 98.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₄₅H₆₁N₄O₉PSi.

Dmt-Du Amidite, CAS: 109389-30-2, stock: 5g, assay: 98%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₃₉H₄₇N₄O₈P.

5-Chlorouracil-15N2,13C, CAS: 1185171-08-7, stock: 1.6g, assay: 96.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₃¹³CH₃Cl¹⁵N₂O₂.

5-Cyanouracil, CAS: 4425-56-3, stock: 5.1g, assay: 96.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₅H₃N₃O₂.

5-Ethyl-2-thiouracil, CAS: 34171-37-4, stock: 2.6g, assay: 98.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₆H₈N₂OS.

5-Ethyluracil, CAS: 4212-49-1, stock: 3g, assay: 96.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₆H₈N₂O₂.

Fialuridine 5’-Monophosphate, CAS: 99891-31-3, stock: 3.1g, assay: 98.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₉H₁₁FIN₂O₈P.

5-Fluoro-uracil-2-14C, CAS: 766-63-2, stock: 6.1g, assay: 96.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₃¹⁴CH₃FN₂O₂.

Human DUT(Deoxyuridine 5’-triphosphate nucleotidohydrolase, mitochondrial) ELISA Kit (96T), CAS: /, stock: 8.3g, assay: 98%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  /.

Human TRUB1(Probable tRNA pseudouridine synthase 1) ELISA Kit (96T), CAS: /, stock: 3.2g, assay: 98.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  /.

Human UPP2(Uridine Phosphorylase 2) ELISA Kit (96T), CAS: /, stock: 8.8g, assay: 97.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  /.

5-Formyl Uracil, CAS: 1195-08-0, stock: 5.3g, assay: 98.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₅H₄N₂O₃.

5-Hydroxy-2’-deoxycytidine, CAS: 52278-77-0, stock: 4.7g, assay: 97.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₉H₁₃N₃O₅.

5-Hydroxy-2’-deoxycytidine-13C,15N2, CAS: /, stock: 7.7g, assay: 97.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₈¹³CH₁₃N¹⁵N₂O₅.

5-Hydroxymethyl-6-azauracil, CAS: 4449-450, stock: 5g, assay: 96.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₄H₅N₃O₃.

MRS 2768 Tetrasodium Salt, CAS: /, stock: 3g, assay: 98.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₅H₁₆N₂Na₄O₁₈P₄.

5-Hydroxymethyluracil, CAS: 4433-40-3, stock: 4.8g, assay: 96.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₅H₆N₂O₃.

MRS 2768 Tetrasodium Salt, CAS: /, stock: 3.8g, assay: 96.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₅H₁₆N₂O₁₈P₄Na₄.

5-Iodouridine, CAS: 1024-99-3, stock: 9.6g, assay: 96.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₉H₁₁IN₂O₆.

5-Nitro-6-(D-ribitylamino)-2,4(1H,3H)-pyrimidinedione, CAS: 52918-39-5, stock: 4.6g, assay: 98.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₉H₁₄N₄O₈.

5-Nitrouracil, CAS: 611-08-5, stock: 6.1g, assay: 98.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₄H₃N₃O₄.

5-Propyl-2-thiouracil, CAS: 2954-52-1, stock: 5.5g, assay: 96.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₇H₁₀N₂OS.

5-Tributylstannyl-1,3-dimethyluracil, CAS: 103408-63-5, stock: 4g, assay: 96.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₈H₃₄N₂O₂Sn.

5-Vinyluracil, CAS: 37107-81-6, stock: 5.3g, assay: 97.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₆H₆N₂O₂.

5-[(2-Cyanoethoxy)methyl]-2’-deoxycytidine, CAS: 188411-05-4, stock: 9.1g, assay: 98.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₃H₁₈N₄O₅.

5-[Bis(2-chloroethyl)amino]pyrimidine-2,4-diol, CAS: 66-75-1, stock: 8.6g, assay: 96.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₈H₁₁N₃O₂Cl₂.

6-(3-Chloropropylamino)-1,3-dimethyl-2,4(1H,3H)-pyrimidinedione, CAS: 34654-81-4, stock: 2.8g, assay: 96.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₉H₁₄ClN₃O₂.

6-(Chloromethyl)uracil, CAS: 18592-13-7, stock: 7.2g, assay: 96.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₅H₅ClN₂O₂.

Nε-2-Azidoethyloxycarbonyl-L-lysine, CAS: 1167421-25-1, stock: 9.6g, assay: 97.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₉H₁₇N₅O₄.

6-(N-Methyl-3,4-xylidino)uracil, CAS: 36995-89-8, stock: 1.4g, assay: 97.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₃H₁₅N₃O₂.

6-Amino-1,3-dibutyluracil, CAS: 41862-16-2, stock: 9.5g, assay: 97.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₂H₂₁N₃O₂.

6-Amino-1,3-dimethyl-5-nitrosouracil, CAS: 3346-61-0, stock: 6.8g, assay: 96.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₆H₈N₄O₃.

Pentafluorophenylphosphate, CAS: 857186-81-3, stock: 5.2g, assay: 98.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₆H₂F₅O₄P.

6-Amino-1,3-dipropyl-5-nitrosouracil, CAS: 81250-33-1, stock: 7.6g, assay: 98.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₀H₁₆N₄O₃.

Protected U-U 5’-CEP, CAS: 915098-72-5, stock: 5.5g, assay: 98.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₄₀H₆₁N₇O₁₇P₂Si.

6-Amino-1,3-dipropyluracil, CAS: 41862-14-0, stock: 1.9g, assay: 98.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₀H₁₇N₃O₂.

6-Amino-1-benzyl-3-methyl-5-(N-formyl-N-methyl)uracil, CAS: 72816-91-2, stock: 5.7g, assay: 98.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₄H₁₆N₄O₃.

PSB 0474, CAS: 917567-60-3, stock: 2.5g, assay: 98.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₇H₁₈N₂Na₂O₁₃P₂.

PSB 1114, CAS: 1657025-60-9, stock: 7g, assay: 97.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₀H₁₁F₂N₂Na₄O₁₃P₃S.

6-Amino-1-benzyl-5-(N-formyl-N-methyl)uracil, CAS: 72816-89-8, stock: 5.2g, assay: 98.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₃H₁₄N₄O₃.

6-Amino-1-benzyl-5-bromouracil, CAS: 72816-87-6, stock: 9.6g, assay: 98.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₁H₁₀BrN₃O₂.

6-Amino-1-benzyl-5-methylaminouracil, CAS: 72816-88-7, stock: 7.7g, assay: 96.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₂H₁₄N₄O₂.

6-Amino-1-benzyluracil, CAS: 41862-11-7, stock: 8.8g, assay: 96.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₁H₁₁N₃O₂.

6-Amino-1-isobutyl-3-methyl-5-nitroso-2,4-pyrimidinedione, CAS: 54052-67-4, stock: 5.9g, assay: 98%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₉H₁₄N₄O₃.

6-Amino-1-methyl-5-(methylamino)uracil, CAS: 55441-70-8, stock: 7.5g, assay: 97.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₆H₁₀N₄O₂.

6-Amino-1-methyl-5-(propylamino)uracil, CAS: 125092-42-4, stock: 3.1g, assay: 96.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₈H₁₄N₄O₂.

6-Amino-1-methyl-5-nitrosouracil, CAS: 6972-78-7, stock: 3.6g, assay: 98.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₅H₆N₄O₃.

6-Amino-1-methyluracil, CAS: 2434-53-9, stock: 7g, assay: 96.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₅H₇N₃O₂.

Raluridine, CAS: 119644-22-3, stock: 7g, assay: 98.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₉H₁₀ClFN₂O₄.

6-Amino-2,3-dihydro-1-[(tetrahydro-2-furanyl)methyl]-2-thioxo-4(1H)-pyrimidinone, CAS: 618913-50-1, stock: 3.8g, assay: 98.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₉H₁₃N₃O₂S.

Rat BrdU(Bromodeoxyuridine) ELISA Kit (96T), CAS: /, stock: 9.5g, assay: 98.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  /.

RO 2433, CAS: 863329-66-2, stock: 3.9g, assay: 96.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₀H₁₃FN₂O₅.

6-Amino-2,4-dihydroxypyrimidine, CAS: 873-83-6, stock: 7.9g, assay: 97.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₄H₅N₃O₂.

6-Amino-2,4-dihydroxypyrimidine-13C,15N2, CAS: 1895922-32-3, stock: 5g, assay: 98.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₃¹³CH₅N¹⁵N₂O₂.

RO 2433 Dibenzoate, CAS: 863329-65-1, stock: 7.7g, assay: 96.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₄H₂₁FN₂O₇.

RO 2433-13CD3, CAS: 1256490-42-2, stock: 2.6g, assay: 98.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₉¹³CH₁₀D₃FN₂O₅.

6-Amino-2-methylthio-3-methyluracil, CAS: 54030-56-7, stock: 9.3g, assay: 98.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₆H₉N₃OS.

6-Amino-2-thiouracil Hydrate, CAS: 65802-56-4, stock: 8.7g, assay: 96.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₄H₇N₃O₂S.

S4-(2-Cyanoethyl)-4-thio-2’-deoxyuridine, CAS: 136055-15-7, stock: 1.2g, assay: 96.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₂H₁₅N₃O₄S.

Sodium Tetraborate Decahydrate, CAS: 1303-96-4, stock: 6.1g, assay: 97.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  B₄H₂₀Na₂O₁₇.

6-Amino-2-thiouracil-13C, CAS: 1246816-15-8, stock: 8g, assay: 97.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₃¹³CH₅N₃OS.

6-Amino-2-thiouracil-13C2, CAS: 1330170-14-3, stock: 4.5g, assay: 97.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂¹³C₂H₅N₃OS.

6-Amino-3-methyluracil, CAS: 21236-97-5, stock: 8.8g, assay: 98%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₅H₇N₃O₂.

6-Amino-3-methyluracil-d3, CAS: 1246820-43-8, stock: 5.6g, assay: 97.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₅H₄D₃N₃O₂.

6-Amino-4-methoxy-2-methylthiouracil, CAS: 3289-53-0, stock: 5g, assay: 98.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₆H₉N₃OS.

Solasodine, CAS: 126-17-0, stock: 3g, assay: 98.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₇H₄₃NO₂.

6-Amino-5-1,3-dimethyl-5-(formamido)uracil, CAS: 7597-60-6, stock: 3.9g, assay: 96.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₇H₁₀N₄O₃.

6-Amino-5-bromo-1-methyluracil, CAS: 14094-37-2, stock: 2.9g, assay: 97.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₅H₆BrN₃O₂.

6-Amino-5-nitroso-2-thiouracil, CAS: 1672-48-6, stock: 4.1g, assay: 98.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₄H₄N₄O₂S.

6-Amino-5-nitroso-2-thiouracil-13C,15N, CAS: 1246814-68-5, stock: 2.2g, assay: 96.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₃¹³CH₄N₃¹⁵NO₂S.

6-Amino-5-nitroso-3-methyluracil, CAS: 61033-04-3, stock: 1.5g, assay: 96.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₅H₆N₄O₃.

6-Amino-5-nitroso-3-methyluracil-d3, CAS: 1246819-56-6, stock: 1.1g, assay: 97.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₅H₃D₃N₄O₃.

6-Amino-5-nitrosouracil, CAS: 5442-24-0, stock: 5.6g, assay: 97.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₄H₄N₄O₃.

6-Amino-5-nitrosouracil-13C,15N2, CAS: /, stock: 6g, assay: 98.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₃¹³CH₄N₂¹⁵N₂O₃.

6-Amino-5-nitrosouracil-13C2, CAS: /, stock: 10g, assay: 99%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂¹³C₂H₄N₄O₃.

6-Amino-5-nitrouracil, CAS: 3346-22-3, stock: 1.8g, assay: 97.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₄H₄N₄O₄.

6-Amino-5-[(cyclopentanecarbonyl)amino]-1,3-dimethyl Uracil, CAS: 887352-43-4, stock: 1.9g, assay: 98.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₂H₁₈N₄O₃.

6-Azauracil, CAS: 461-89-2, stock: 1.1g, assay: 96.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₃H₃N₃O₂.

Triphenylphosphine Hydrobromide, CAS: 6399-81-1, stock: 4.2g, assay: 96.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₈H₁₆BrP.

6-Azauridine, CAS: 54-25-1, stock: 2.8g, assay: 98.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₈H₁₁N₃O₆.

Trisodium UDP-glucuronic Acid, CAS: 63700-19-6, stock: 5.2g, assay: 96.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₅H₂₂N₂Na₃O₁₈P₂.

UDP Disodium Salt, CAS: 27821-45-0, stock: 6.2g, assay: 96.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₉H₁₂N₂Na₂O₁₂P₂.

6-​Phenyl-​2-​thiouracil, CAS: 36822-11-4, stock: 5g, assay: 98.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₀H₈N₂OS.

6-Benzyl-2-thiouracil, CAS: 6336-50-1, stock: 8.1g, assay: 96%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₁H₁₀N₂OS.

UDP Disodium Salt Hydrate, CAS: /, stock: 6.1g, assay: 96.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₉H₁₂N₂Na₂O₁₂P₂ • xH ₂O.

6-Chloro-1,3-dimethyl-5-nitrouracil, CAS: 1203-25-4, stock: 1.5g, assay: 96.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₆H₆ClN₃O₄.

6-Chloro-1,3-dimethyluracil, CAS: 6972-27-6, stock: 7.4g, assay: 96.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₆H₇ClN₂O₂.

6-Chloro-1-methyluracil, CAS: 31737-09-4, stock: 5.2g, assay: 97.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₅H₅ClN₂O₂.

6-Chloro-3-methyluracil, CAS: 4318-56-3, stock: 3.2g, assay: 98.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₅H₅ClN₂O₂.

UDP-a-L-Rha Sodium Salt, CAS: 1526988-33-9, stock: 6.2g, assay: 97.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₅H₂₂N₂Na₂O₁₆P₂.

6-Chloro-5-formyl-1,3-dimethyluracil, CAS: 35824-85-2, stock: 1.3g, assay: 98.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₇H₇ClN₂O₃.

6-Chlorouracil, CAS: 4270-27-3, stock: 2.4g, assay: 97.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₄H₃ClN₂O₂.

3,4-Bis(phenylmethoxy)benzeneethanol 1-Acetate, CAS: /, stock: 3.8g, assay: 97.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₄H₂₄O₄.

3-(Phenylmethoxy)-4-(sulfooxy)benzeneethanol 1-Acetate Sodium Salt, CAS: /, stock: 7.9g, assay: 98.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₇H₁₇NaO₇S.

UDP-β-L-Rhamnose Disodium Salt, CAS: /, stock: 9.7g, assay: 97.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₅H₂₂N₂Na₂O₁₆P₂.

6-Formyluracil, CAS: 36327-91-0, stock: 2.2g, assay: 98.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₅H₄N₂O₃.

3-(Phenylmethoxy)-4-(sulfooxy)benzeneethanol Sodium Salt, CAS: /, stock: 9g, assay: 97.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₅H₁₅NaO₆S.

Uridine 2’,​3’,​5’-​Tribenzoate, CAS: 1748-04-5, stock: 7.4g, assay: 97.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₃₀H₂₄N₂O₉.

6-Methyluracil, CAS: 626-48-2, stock: 10g, assay: 96.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₅H₆N₂O₂.

6-Uracilylmethylene Triphenylphosphonium Chloride, CAS: 36803-39-1, stock: 6.2g, assay: 98.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₃H₂₀ClN₂O₂P.

Uridine 5’-Diphosphate Sodium Salt, CAS: 21931-53-3, stock: 2.3g, assay: 98.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₉H₁₄N₂O₁₂P₂•xNa.

Uridine 5’-Diphosphate Sodium Salt, CAS: 21931-53-3, stock: 3.3g, assay: 97.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₉H₁₄N₂O₁₂P₂ • 2Na.

Amisometradine, CAS: 550-28-7, stock: 7g, assay: 96%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₉H₁₃N₃O₂.

Amisometradine-d3, CAS: /, stock: 3.8g, assay: 98.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₉H₁₀D₃N₃O₂.

Uridine 5’-Diphosphate-13C,15N2, CAS: /, stock: 5.6g, assay: 96.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₈¹³CH₁₄¹⁵N₂O₁₂P₂.

4-Hydroxy-3-(phenylmethoxy)-benzeneethanol 1-Acetate, CAS: /, stock: 3.2g, assay: 97.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₇H₁₈O₄.

4-O-Benzyl-3-acetyloxy Tyrosol α-Acetate, CAS: 1798042-57-5, stock: 1.7g, assay: 97.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₉H₂₀O₅.

4-O-Benzyl-3-hydroxy Tyrosol 3-Sulfate Sodium Salt, CAS: 1797987-18-8, stock: 6g, assay: 96.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₅H₁₅NaO₆S.

Uridine 5’-Diphospho-N-Acetylquinovosamine Disodium Salt, CAS: 131564-52-8, stock: 3.2g, assay: 96.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₇H₂₅N₃Na₂O₁₆P₂.

4-O-Benzyl-3-hydroxy Tyrosol α-Acetate, CAS: 1333081-71-2, stock: 4.8g, assay: 97.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₇H₁₈O₄.

Uridine 5’-Monophosphate, CAS: 58-97-9, stock: 2.7g, assay: 97.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₉H₁₃N₂O₉P.

4-O-Benzyl-3-hydroxy Tyrosol α-Acetate-3-Sulfate Sodium Salt, CAS: 1797006-03-1, stock: 2.3g, assay: 96.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₇H₁₇NaO₇S.

Hydroxy Tyrosol  (>85%), CAS: 10597-60-1, stock: 1.3g, assay: 97.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₈H₁₀O₃.

Uridine 5’-Monophosphate Disodium Salt, CAS: 3387-36-8, stock: 9.7g, assay: 97.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₉H₁₁N₂Na₂O₉P.

Hydroxy Tyrosol  (>98%, Synthetic), CAS: 10597-60-1, stock: 4.9g, assay: 97%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₈H₁₀O₃.

Hydroxy Tyrosol 3-Sulfate Sodium Salt, CAS: 1391053-88-5, stock: 6.7g, assay: 97.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₈H₉NaO₆S.

Uridine 5’-Tetraphosphate, CAS: 10003-94-8, stock: 2.2g, assay: 97.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₉H₁₆N₂O₁₈P₄.

Clevudine, CAS: 163252-36-6, stock: 3.6g, assay: 98.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₀H₁₃FN₂O₅.

Hydroxy Tyrosol 4-Sulfate Sodium Salt, CAS: 1817821-22-9, stock: 6.3g, assay: 97.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₈H₉NaO₆S.

Uridine 5’-Triphosphate Tris Salt, CAS: 108321-53-5, stock: 3.8g, assay: 97.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₉H₁₅N₂O₁₅P₃ • x( C₄H₁₁NO₃).

Uridine 5’-Triphosphate Trisodium Salt Hydrate, CAS: /, stock: 4.3g, assay: 96.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₉H₁₂N₂Na₃O₁₅P₃•xH₂O.

Hydroxy Tyrosol Sulfate Triethylammonium Salt, CAS: /, stock: 9.6g, assay: 98.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₄H₂₅NO₆S.

Dialuric Acid, CAS: 444-15-5, stock: 3.8g, assay: 97.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₄H₄N₂O₄.

Hydroxy Tyrosol-d4, CAS: 1330260-89-3, stock: 8.2g, assay: 97.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₈H₆D₄O₃.

Uridine Diphosphate-GlcNaz, CAS: 1355005-50-3, stock: 8.2g, assay: 98.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₅H₂₁N₅Na₂O₁₆P₂.

Dialuric Acid-13C,15N2, CAS: 1391053-76-1, stock: 9g, assay: 98%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₃¹³CH₄¹⁵N₂O₄.

Dihydro Uracil, CAS: 504-07-4, stock: 4.4g, assay: 98.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₄H₆N₂O₂.

Hydroxy Tyrosol-d4 Sulfate Sodium Salt, CAS: /, stock: 5.9g, assay: 98%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₈H₅D₄NaO₆S.

Uridine Monophosphate Disodium Salt (2’- and 3’- mixture), CAS: /, stock: 8.1g, assay: 98.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₉H₁₁N₂Na₂O₉P.

Uridine-13C,15N2 2’,​3’,​5’-​Tribenzoate, CAS: 2082749-94-6, stock: 2.7g, assay: 98%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₉¹³CH₂₄¹⁵N₂O₉.

Dihydro Uracil-d4, CAS: 334473-41-5, stock: 5.1g, assay: 97.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₄H₂D₄N₂O₂.

Uridine-13C5 5’-Monophosphate Disodium Salt, CAS: /, stock: 4.4g, assay: 97.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₄¹³C₅H₁₁N₂Na₂O₉P.

Uridine-2-13C-1,3-15N2, CAS: 369656-75-7, stock: 2.1g, assay: 96.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₈¹³CH₁₂¹⁵N₂O₆.

Eniluracil, CAS: 59989-18-3, stock: 3g, assay: 96.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₆H₄N₂O₂.

Salidroside, CAS: 10338-51-9, stock: 7.4g, assay: 98.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₄H₂₀O₇.

Uridine-2’,3’-cyclic Monophosphate Sodium Salt, CAS: 15718-50-0, stock: 9.6g, assay: 96.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₉H₁₀N₂NaO₈P.

Uridine-3’,5’-cyclic Monophosphate Sodium Salt, CAS: 56632-58-7, stock: 4.6g, assay: 98%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₉H₁₀N₂NaO₈P.

Eniluracil-13C,15N2, CAS: 1329556-69-5, stock: 4.4g, assay: 97.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₅¹³CH₄¹⁵N₂O₂.

Uridine-3’,5’-cyclic-13C5 Monophosphate Sodium Salt, CAS: /, stock: 4.1g, assay: 98.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₄¹³C₅H₁₀N₂NaO₈P.

Ethyl 2-thiouracil-5-carboxylate, CAS: 38026-46-9, stock: 2.6g, assay: 97.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₇H₈N₂O₃S.

Uridine-5’-triphosphate Trisodium Salt Dihydrate, CAS: 116295-90-0, stock: 3.5g, assay: 98.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₉H₁₆N₂Na₃O₁₇P₃.

Fialuridine, CAS: 69123-98-4, stock: 5g, assay: 96.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₉H₁₀FIN₂O₅.

Fialuridine-15N2,13C, CAS: /, stock: 9.9g, assay: 98.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₈¹³CH₁₀FI¹⁵N₂O₅.

UTPγS Trisodium Salt, CAS: 1266569-94-1, stock: 3.8g, assay: 98.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₉H₁₂N₂Na₃O₁₄P₃S.

Vinyl methyl sulfone, CAS: 02/02/3680, stock: 8.1g, assay: 98.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₃H₆O₂S.

Furan-3-methanol-d2, CAS: 1216686-59-7, stock: 3.8g, assay: 98.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₅H₄D₂O₂.

Zebularine, CAS: 06/10/3690, stock: 7.9g, assay: 96.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₉H₁₂N₂O₅.

β-Pseudouridine, CAS: 1445-07-4, stock: 8.1g, assay: 98.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₉H₁₂N₂O₆.

β-Pseudouridine-13C, 15N2, CAS: /, stock: 1.4g, assay: 97.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₈¹³CH₁₂¹⁵N₂O₆.

Lenacil, CAS: 01/08/2164, stock: 4.9g, assay: 98.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₃H₁₈N₂O₂.

Lenacil-d4, CAS: /, stock: 8.4g, assay: 96.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₃H₁₄D₄N₂O₂.

Lithium Propyl Phosphate, CAS: 4656-39-7, stock: 7.6g, assay: 98.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₃H₇Li₂O₄P.

Lithium Propyl Phosphate-d5, CAS: /, stock: 5.3g, assay: 98.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₃H₂D₅Li₂O₄P.

Mictine, CAS: 642-44-4, stock: 7.9g, assay: 98.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₉H₁₃N₃O₂.

N4-Benzoyl-5-(furan-2-yl)-2’-deoxycytidine, CAS: 1119734-59-6, stock: 9.2g, assay: 98.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₀H₁₉N₃O₆.

N4-[(Dimethylamino)methylidene]-5-[3-oxo-[[6-[(trifluoroacetyl)amino]hexyl]amino]-1-propenyl]-2’-deoxycytidine, CAS: /, stock: 4.4g, assay: 98.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₃H₃₃F₃N₆O₆.

O2,2’-Cyclouridine, CAS: 3736-77-4, stock: 4.5g, assay: 97.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₉H₁₀N₂O₅.

Potassium 1,3-Dimethyluracil-5-trifluoroborate, CAS: 1150654-77-5, stock: 2.7g, assay: 97.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₆H₇BF₃KN₂O₂.

Canada Balsam, Technical Grade, CAS: 8007-47-4, stock: 4.8g, assay: 96.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  N/A.

(2R,3R,4S,5S,6R)-5-(((2S,4R,5S,6S)-5-((tert-Butyldimethylsilyl)oxy)-4-hydroxy-4,6-dimethyltetrahydro-2H-pyran-2-yl)oxy)-2-(((1S,5R,6R,7E,9E,12R,16R,18R,19R)-16-((tert-butyldimethylsilyl)oxy)-6-((((2R,3R,4S,5R,6R)-5-((tert-butyldimethylsilyl)oxy)-3,4-dimethoxy-6-methyltetrahydro-2H-pyran-2-yl)oxy)met, CAS: /, stock: 7.9g, assay: 98.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₆₆H₁₂₁NO₁₈Si₃.

Pseudouridine 5’-Triphosphate Triethylamine Salt,  >85%, CAS: 1175-34-4, stock: 6.8g, assay: 98.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₉H₁₅N₂O₁₅P₃•xC₆H₁₅N.

(2R,3R,4S,5S,6R)-5-(((2S,4R,5S,6S)-5-((tert-Butyldimethylsilyl)oxy)-4-hydroxy-4,6-dimethyltetrahydro-2H-pyran-2-yl)oxy)-2-(((1S,5R,6R,7E,9E,12R,16R,18R,19R)-16-((tert-butyldimethylsilyl)oxy)-6-((((2R,3R,4S,5R,6R)-5-((tert-butyldimethylsilyl)oxy)-3,4-dimethoxy-6-methyltetrahydro-2H-pyran-2-yl)oxy)met, CAS: /, stock: 2.7g, assay: 98.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₆₆H₁₁₈D₃NO₁₈Si₃.

(2R,3R,4S,5S,6R)-5-(((2S,4R,5S,6S)-5-((tert-Butyldimethylsilyl)oxy)-4-hydroxy-4,6-dimethyltetrahydro-2H-pyran-2-yl)oxy)-2-(((1S,5R,6R,7E,9E,12R,16R,18R,19R)-16-((tert-butyldimethylsilyl)oxy)-6-((((2R,3R,4S,5R,6R)-5-((tert-butyldimethylsilyl)oxy)-3,4-dimethoxy-6-methyltetrahydro-2H-pyran-2-yl)oxy)met, CAS: /, stock: 5.9g, assay: 96.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₆₅H₁₁₉NO₁₈Si₃.

rac-1-(Tetrahydro-2-furyl)-5-chlorouracil, CAS: 17902-24-8, stock: 1.1g, assay: 97.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₈H₉ClN₂O₃.

Silver Cyanate, CAS: 3315-16-0, stock: 9.2g, assay: 97.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  AgOCN.

20-Deoxo-20-(1-piperidinyl)tylosin, CAS: 1003024-00-7, stock: 1.8g, assay: 96.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₅₁H₈₈N₂O₁₆.

23-O-Desmycinosyl-tylosin, CAS: 79592-92-0, stock: 9.7g, assay: 97.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₃₆H₆₃NO₁₃.

Sorivudine, CAS: 77181-69-2, stock: 1.9g, assay: 97.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₁H₁₃BrN₂O₆.

2’,4’’’-O-DiTMS Tylosin 3-Methylbytanoate, CAS: /, stock: 3.9g, assay: 98%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₅₇H₁₀₁NO₁₈Si₂.

3-Acetyl-2’,4’’’-O-ditrimethylsilyl-4’’-O-isovaleryltylosin, CAS: /, stock: 1.4g, assay: 96.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₅₉H₁₀₃NO₁₉Si₂.

4’,2’’-O-Di(trimethysilyl)tylosin, CAS: 114442-77-2, stock: 4.6g, assay: 97%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₅₂H₉₃NO₁₇Si₂.

4’’’-O-Chloroacetyl-tylosin, CAS: /, stock: 5.5g, assay: 96.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₄₈H₇₈ClNO₁₈.

Terbacil, CAS: 5902-51-2, stock: 9.4g, assay: 97.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₉H₁₃ClN₂O₂.

4’’’-O-Chloroacetyl-tylosin 3-Acetate, CAS: /, stock: 1.1g, assay: 98.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₅₀H₈₀ClNO₁₉.

4”’-O-Chloroacetyl-4’,2’’-O-di(trimethysilyl)tylosin, CAS: /, stock: 7.7g, assay: 96.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₅₄H₉₄ClNO₁₈Si₂.

Thiouracil-13C,15N2, CAS: /, stock: 7.8g, assay: 97.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₃¹³CH₄¹⁵N₂OS.

4”’-O-Chloroacetyl-4’,2’’-O-di(trimethysilyl)tylosin, CAS: /, stock: 1.2g, assay: 97.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₅₄H₉₄ClNO₁₈Si₂.

4”’-O-Chloroacetyl-4’,2’’-O-di(trimethysilyl)tylosin 3,3’’’-Diacetate, CAS: /, stock: 3.2g, assay: 96.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₅₈H₉₈ClNO₂₀Si₂.

4”’-O-Chloroacetyl-4’,2’’-O-di(trimethysilyl)tylosin 3’’’-Acetate, CAS: /, stock: 2.2g, assay: 96.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₅₆H₉₆ClNO₁₉Si₂.

Thymine, CAS: 65-71-4, stock: 5.8g, assay: 96.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₅H₆N₂O₂.

t-Butyldimethylsilyl Tylosin, CAS: /, stock: 5.2g, assay: 97.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₅₂H₉₁NO₁₇Si.

(1,2,3,4-Tetrahydroquinolin-5-yl)urea, CAS: 1016712-93-8, stock: 5.4g, assay: 96.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₀H₁₃N₃O.

Thymine-13C5, CAS: /, stock: 2.6g, assay: 98.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  ¹³C₅H₆N₂O₂.

t-Butyldimethylsilyl Tylosin Acetate, CAS: /, stock: 5.3g, assay: 97%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₅₄H₉₃NO₁₈Si.

t-Butyldimethylsilyl Tylosin-d3, CAS: /, stock: 8.9g, assay: 97.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₅₈H₁₀₂D₃NO₁₇Si₂.

(1,4-Dioxan-2-ylmethyl)urea, CAS: 1184826-65-0, stock: 4.5g, assay: 97.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₆H₁₂N₂O₃.

(1-Methyl-1H-pyrazol-4-yl)thiourea, CAS: 1154267-67-0, stock: 3g, assay: 99%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₅H₈N₄S.

Thymine-d3, CAS: 68941-98-0, stock: 3.5g, assay: 98.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₅H₃D₃N₂O₂.

t-Butyldimethylsilyl Tylosin-d3 Acetate, CAS: /, stock: 4.5g, assay: 97.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₅₄H₉₀D₃NO₁₈Si.

(1-Methylpiperidin-4-yl)thiourea, CAS: 1096840-97-9, stock: 6.1g, assay: 97.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₇H₁₅N₃S.

(1R)-3-endo-Aminoborneol, CAS: 29900-93-4, stock: 6.3g, assay: 97.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₀H₁₉NO.

(1R,2R)-2-Fluorocyclopentanamine Hydrochloride, CAS: /, stock: 1.7g, assay: 97.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₅H₁₁ClFN.

Tylosin 3-Acetate, CAS: 63409-10-9, stock: 3.1g, assay: 98.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₄₈H₇₉NO₁₈.

(1R,2S)-2-Fluorocyclopentanamine Hydrochloride, CAS: 1955474-71-1, stock: 5.8g, assay: 96.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₅H₁₁ClFN.

Uracil-13C,15N2, CAS: 181517-11-3, stock: 5.3g, assay: 98.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₃¹³CH₄¹⁵N₂O₂.

Tylosin Phosphate, CAS: 1405-53-4, stock: 3.5g, assay: 97.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₄₆H₇₇NO₁₇ • x( H₃O₄P).

Tylosin Tartrate, CAS: 74610-55-2, stock: 8.3g, assay: 98%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₅₀H₈₃NO₂₃.

(2,3-Difluorophenyl)thiourea, CAS: 572889-25-9, stock: 9.4g, assay: 98.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₇H₆F₂N₂S.

Urapidil Hydrochloride, CAS: 64887-14-5, stock: 3g, assay: 98.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₀H₃₀ClN₅O₃.

Urapidil-d4 Hydrochloride, CAS: 1794979-63-7, stock: 5.5g, assay: 98.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₀H₂₆D₄ClN₅O₃.

Tylvalosin, CAS: 63409-12-1, stock: 7.5g, assay: 98.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₅₃H₈₇NO₁₉.

(2,3-Dihydro-1H-inden-5-yl)thiourea, CAS: 117174-86-4, stock: 1.4g, assay: 96.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₀H₁₂N₂S.

(2,4-Dimethylphenyl)thiourea, CAS: 16738-20-8, stock: 7.5g, assay: 97.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₉H₁₂N₂S.

Uridine, CAS: 58-96-8, stock: 5.3g, assay: 96.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₉H₁₂N₂O₆.

Tylvalosin-d9, CAS: /, stock: 9.2g, assay: 97%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₅₃H₇₈D₉NO₁₉.

(2,5-Dimethyl-phenyl)-thiourea, CAS: 16738-19-5, stock: 9.6g, assay: 96%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₉H₁₂N₂S.

(2-Amino-2-methylpropyl)urea Hydrochloride, CAS: 1159824-29-9, stock: 3.1g, assay: 98.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₅H₁₃N₃O  • HCl.

Uridine-5,6-d2, CAS: 40632-21-1, stock: 7.8g, assay: 98.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₉H₁₀D₂N₂O₆.

Uridine-[5’,5’-D2], CAS: 82740-98-5, stock: 5.7g, assay: 97.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₉D₂H₁₀N₂O₆.

(2-Bromophenyl)urea, CAS: 13114-90-4, stock: 1.6g, assay: 96.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₇H₇N₂OBr.

(2-Chloro-acetyl)-urea, CAS: 4791-21-3, stock: 8.2g, assay: 96.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₃H₅ClN₂O₂.

Uridine[1’-D], CAS: /, stock: 7.6g, assay: 96%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₉DH₁₁N₂O₆.

[1’,2’,3’,4’,5’-13C5]Uridine, CAS: 159496-16-9, stock: 5.4g, assay: 97.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₄¹³C₅H₁₂N₂O₆.

(2-Fluoro-5-methylphenyl)thiourea, CAS: 1038356-01-2, stock: 2.8g, assay: 97.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₈H₉N₂FS.

(2-Fluorophenyl)thiourea, CAS: 656-32-6, stock: 5.8g, assay: 97.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₇H₇FN₂S.

[1’-13C]Uridine, CAS: 201996-62-5, stock: 1.3g, assay: 98.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₈¹³CH₁₂N₂O₆.

[2’-13C]Uridine, CAS: 478511-11-4, stock: 4.7g, assay: 98.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₈¹³CH₁₂N₂O₆.

(2-Hydroxy-5-methylphenyl)thiourea, CAS: 500284-61-7, stock: 2.9g, assay: 97.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₈H₁₀N₂OS.

(2-Methoxyethyl)thiourea, CAS: 102353-42-4, stock: 4.9g, assay: 98.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₄H₁₀N₂OS.

[3’-13C]Uridine, CAS: 478511-14-7, stock: 2.6g, assay: 97.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₈¹³CH₁₂N₂O₆.

[5’-13C]Uridine, CAS: 478511-16-9, stock: 6.5g, assay: 97.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₈¹³CH₁₂N₂O₆.

(2-Methoxyphenyl)thiourea, CAS: 1516-37-6, stock: 1.2g, assay: 97.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₈H₁₀N₂OS.

(2-Methoxyphenyl)urea, CAS: 135-92-2, stock: 4.6g, assay: 97%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₈H₁₀N₂O₂.

(2-Methylallyl)urea, CAS: 89487-41-2, stock: 6.6g, assay: 98.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₅H₁₀N₂O.

(2-Nitrophenyl)phosphoric Triamide, CAS: 874819-71-3, stock: 7.7g, assay: 97.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₆H₉N₄O₃P.

(2-Phenoxyphenyl)urea, CAS: 1016698-86-4, stock: 1.8g, assay: 97.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₃H₁₂N₂O₂.

(3,4-Dihydro-2H-1,5-benzodioxepin-7-yl)thiourea, CAS: 1152526-78-7, stock: 7.6g, assay: 97.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₀H₁₂N₂O₂S.

(3,5-Difluoro-phenyl)acetic Acid Methyl Ester, CAS: 210530-70-4, stock: 7.6g, assay: 97.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₉H₈O₂F₂.

(3-Aminophenyl)-urea mono hydrochloride, CAS: 59690-88-9, stock: 3.1g, assay: 96%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₇H₁₀ClN₃O.

(3-Ethynylphenyl)urea, CAS: 1017034-89-7, stock: 3.2g, assay: 96.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₉H₈N₂O.

(3-Fluoro-4-methoxyphenyl)thiourea, CAS: 1097032-85-3, stock: 3.5g, assay: 99%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₈H₉N₂OFS.

(3-Fluorobenzoyl)phosphoramidic Dichloride-D4, CAS: /, stock: 4.2g, assay: 97%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₇HD₂Cl₂F₃NO₂P.

Benzyl ((2S,3S,4S,6R)-4-(dimethylamino)-2-(((2S,3S,4S,5S,8R,10S,11R,12R,13R,14R)-2-ethyl-3,4,10-trihydroxy-13-(((2R,4R,5S,6S)-5-hydroxy-4-methoxy-4,6-dimethyl-5-((propylamino)methyl)tetrahydro-2H-pyran-2-yl)oxy)-3,5,8,10,12,14-hexamethyl-15-oxo-1-oxa-6-azacyclopentadecan-11-yl)oxy)-6-methyltetrahydr, CAS: /, stock: 4g, assay: 97%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₄₉H₈₅N₃O₁₄.